The tachykinin receptor. Part II: Distribution and pathophysiological roles

Neuropeptides

Volumn 32, Issue 1, 1998, Pages 1-49

  Quartara, L ^a   Maggi, C A ^a  

^a Menarini Ricerche SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2 BENZHYDRYL 3 (2 IODOBENZYLAMINO)QUINUCLIDINE; 2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 2 BENZYL 1 (3,5 DIMETHYLBENZOYL) 4 (4 QUINOLINYLMETHYLAMINO)PIPERIDINE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; 3 (2 METHOXYBENZYLAMINO) 2 PHENYLPIPERIDINE; 3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE; 4 (2 METHOXYPHENYL) 2 [2 (2 METHOXYPHENYL)PROPIONYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 OL; 5 [[3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYL 1 PIPERIDINYL]METHYL] 1,2 DIHYDRO 3H 1,2,4 TRIAZOL 3 ONE; FK 224; GR 73362; L 668169; L 743310; LANEPITANT; LY 306740; N BENZYL N2 [4 HYDROXY 1 [(1 METHYL 1H INDOL 3 YL)CARBONYL]PROLYL] N METHYL 3 (2 NAPHTHYL)ALANINAMIDE; NEUROKININ 1 RECEPTOR; NEUROKININ 1 RECEPTOR AGONIST; NEUROKININ 1 RECEPTOR ANTAGONIST; NOLPITANTIUM; PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN]; TACHYKININ RECEPTOR; UNCLASSIFIED DRUG;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ARTHRITIS; ASTHMA; CARDIOVASCULAR AUTOREGULATION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INFLAMMATION; INTESTINE MOTILITY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRANASAL DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; MICTURITION REFLEX; MIGRAINE; MOUSE; NEUROGENIC BLADDER; NEUROPHARMACOLOGY; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RAT; REVIEW; SPINAL CORD; SYNAPTIC TRANSMISSION; TISSUE DISTRIBUTION; TOPICAL DRUG ADMINISTRATION; URINE INCONTINENCE; VOMITING; ANIMAL; BRAIN; BRAIN LEVEL; CHEMISTRY; NEUROLOGIC DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANIMALS; BRAIN; BRAIN CHEMISTRY; HUMANS; INFLAMMATION; NERVOUS SYSTEM DISEASES; PERIPHERAL NERVOUS SYSTEM; RECEPTORS, NEUROKININ-1; SPINAL CORD;

EID: 0031594899     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(98)90015-4     Document Type: Article

References (644)

1. 1 receptor. Part I: ligands and mechanisms of cellular activation. Neuropeptides 1997; 31; 537-563
2. Henry J L. Discussion of nomenclature for tachykinins and tachykinin receptors. Substance P and Neurokinins. New York: Springer-Verlag, 1987: xvii.
3. Yokota Y, Sasai Y, Tanaka K, et al. Molecular characterization of a functional cDNA for rat receptor. J Biol Chem 1989; 264: 17469-17652.
4. Hershey A D, Krause J E. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science 1990; 247: 958-962.
5. Hastrup H, Schwartz T W. Septide and neurokinin A are high affinity ligands on the NK1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Letters 1996; 399: 264-266.
6. Maggi C A, Schwartz T W. The dual nature of the tachykinin NK1 receptor. Trends Pharmacol Sci 1997; 18: 351-354
7. Yanagisawa M, Otsuka M. Pharmacological profile of a tachykinin antagonist, spantide, as examined on rat spinal cord motorneurones. Br J Pharmacol 1990; 100: 711-716.
8. 1 receptor ligands show two distinct pharmacological profiles in rabbit iris sphincter. Br J Pharmacol 1994; 111: 48P.
9. Maggi C A, Patacchini R, Rovero P, Giachetti A. Tachykinin receptors and receptor antagonists. J Autonom Pharmacol 1993; 13: 958-962.
10. Regoli D, Boudon A, Fauchere J. Receptors and antagonists for substance P and related peptides. Pharmacol Rev 1994; 46: 551-599.
11. Maggi C A. The mammalian tachykinin receptors. Gen Pharmac 1995; 26: 911-944.
12. 125I]physalaemin. Brain Res 1985; 332: 299-307.
13. Dam T V, Quirion R. Pharmacological characterization and autoradiographic characterization of substance P receptors in guinea-pig brain. Peptides 1986; 7: 855-864.
14. Danks J A, Rothman R B, Cascieri M A, Chicchi G G, Liang T, Herkenham M. A comparative autoradiographic study of the distributions of substance P and eledoisin binding sites in rat brain. Brain Res 1986; 3865: 273-281.
15. 3 ligands) in the rat brain. Peptides 1988; 9: 227-241.
16. Sivam S P, Krause JE. Tachykinin systems in the spinal cord and basal ganglia: influence of neonatal capsaicin treatment or dopaminergic intervention on levels of peptides SP-encoding mRNAs and substance P receptor mRNA. J Neurochemistry 1992; 59: 2278-2284.
17. 1) receptor in the central nervous system. Mol Brain Res 1993; 18: 43-58.
18. Aubry J M, Lundstrom K, Kawashima E, et al. NK1 receptor expression by cholinergic interneurons in human striatum. Neuroreport 1994; 5: 1597-1600.
19. Whitty CJ, Walker P D, Goebel D J, Poosch M S, Bannon M J. Quantitation, cellular localization and regulation of neurokinin receptor gene expression within the rat substantia nigra. Neuroscience 1995; 64: 419-425.
20. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Immunohistochemical localization of Substance P receptor in the central nervous system of the adult rat. J Comp Neurology 1994; 347: 249-274.
21. Otsuka M, Yoshioka K. Neurotransmitter function of mammalian tachykinins. Physiol Reviews 1993; 73: 229-307.
22. 1 tachykinin receptor gene expression during early postnatal development of rat brain. Neuroscience 1996; 74: 845-853.
23. Herkenham M. Mismatches between neurotransmitter and receptor localizations in brain: observations and implications. Neuroscience 1987; 23: 1-38.
24. Elliott P J, Mason G S, Graham E A, Turpin M P, Hagan R M. Modulation of the rat mesolimbic dopamine pathway by neurokinins. Behav Brain Res 1992; 51: 77-82.
25. 1 receptor activation in gerbils. Eur J Pharmacol 1994; 253: 245-252.
26. 1 tachykinin receptor agonist. Brain Res 1995; 700: 115-120.
27. 3 receptor agonists in the guinea-pig. Br J Pharmacol 1995; 116: 2496-2502.
28. Iversen L L Central actions of substance P and related tachykinin. J Psychopharmacol 1989; 3: 1-6.
29. Sivam S P, Krause J E, Takeuchi K, Li S, McGinty J, Hong J S. Lithium increases rat striatal β- and γ-preprotachykinin messenger RNAs. J Pharmacol Exp Ther 1989 248: 1297-1301.
30. 1 receptors in the striatonigral system. Synapse 1990; 6: 1-9.
31. Shibata K, Haverstick D M, Bannon M J. Tachykinin gene expression in rat limbic nuclei: modulation by dopamine antagonists. J Pharmacol Exp Ther 1990; 255: 388-392.
32. Shirayama Y, Mitsushio H, Takashima M, Ichikawa H, Takayashi K. Reduction of substance P after chronic antidepressant treatment in the striatum, substantia nigra and amygdala of the rat. Brain Res 1996; 739: 70-78.
33. 1 receptor agonist, is enhanced in chronically neuroleptic-treated rats. Behav Brain Research 1993; 57: 93-99.
34. 2 receptor antagonist raclopride: correlation with extracellular acetylcholine levels in striatum. J Pharmacol Exp Ther 1995; 274: 928-936.
35. 1 receptor antagonist on midbrain dopamine neurons in the rat: a single unit extracellular recording study. Synapse 1996; 22: 35-45.
36. 1 receptors modifies some of the naloxone precipitated morphine withdrawal signs in rats. Neurosci Letters 1993; 156: 135-140.
37. 1 receptor. J Pharmacol Exp Ther 1993; 267: 472-479.
38. Krase W, Koch M, Schnitzler H U. Substance P is involved in the sensitization of the acoustic startle response by footshocks in rats. Behav Brain Res 1994; 63: 81-88.
39. Shaikh M B, Steinberg A, Siegel A. Evidence that SP is utilized in medial amygdaloid facilitation of defensive rage behaviour in the cat. Brain Res 1993; 625: 283-294.
40. Teixeira R M, Santos A R S, Ribeiro S J, Calixto J B, Rae G A, De Lima T C M. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behaviour in mice. Eur J Pharmacol 1996; 311: 7-14.
41. 1) receptor antagonist (±) CP 96345 causes sedation and motor impairment of Swiss albino mice in the black-and-white box behavioral paradigm. Neurosci Letters 1992; 143: 169-172.
42. 1 receptor knockout mice. Soc Neurosci Abst 1997; 23: 2354.
43. De Felipe C, O'Brien J A, Palmer J A, Doyle C A, Smith A J H, Hunt S P. Characterization of the NK1 receptor knockout mouse: alterations in nociceptive behaviour. Soc Neurosci Abst 1997; in press.
44. Narumi S, Fujita T. Stimulatory effects of substance P and NGF on neuritic outgrowth in embryonic dorsal root ganglia. Neuropharmacology 1978; 17: 73-76.
45. Narumi S, Maki Y. Stimulatory effects of substance P on neurite extension and cAMP levels in cultured neuroblastoma cells. Neurochemistry 1978; 30: 1321-1326.
46. Iwasaki Y, Kinoshita M, Ikeda K, Takamiya K, Shiojima T. Trophic effects of various neuropeptides on the cultured ventral spinal cord of rat embryo. Neurosci Letters 1989; 101: 316-320.
47. Calvo N, Reiriz J, Pérez-Navarro E, Alberch J. Tachykinins protect chlinergic neurons from quinolinic acid excitotoxicity in striatal cultures. Brain Res 1996; 740: 323-328.
48. Jonsson G, Hallman H. Substance P counteracts neurotoxin damage on norepinephrine neurons in rat brain during ontogeny. Science 1982; 215: 75-77.
49. 1 receptor by floor plate cells in the embryonic rat spinal cord and brainstem. J Physiology 1995; 486: 139-148.
50. De Felipe C, Pinnock R D, Hunt S P. Modulation of chemotropism in the developing spinal cord by substance P. Science 1995; 267: 899-902.
51. 1 tachykinin receptor gene expression during early postnatal development of rat brain. Neuroscience 1996; 74: 845-853.
52. Baker R. Substance P and neurodegenerative disorders. A speculative review. Neuropeptides 1991; 20: 73-78.
53. Yankner B A, Duffy L K, Kirschner D A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin peptides. Science 1990; 250: 279-282.
54. Kowall N W, Beal M F, Busciglio J, Duffy L K, Yankner B A. An in vivo model for the neurodegenerative effect of b amyloid and protection by substance P. Proc Natl Acad Sci USA 1991; 88: 7247-7251.
55. 1 substance P receptors. Bochem Biophys Res Comm 1993; 193: 624-630.
56. Mitsuhashi M, Akitaya T, Turk C W, Payan D G. Amyloid β protein substituent peptides do not interact with the SP receptor expressed in cultured cells. Mol Brain Res 1991; 11: 177-180.
57. Rovero P, Patacchini R, Renzetti A R, et al. Interaction of amyloid β protein (25-35) with tachykinin receptors. Neutopeptides 1992; 22: 99-101.
58. Maggio J E, Stimson E R, Ghilardi J R. Reversible in vitro growth of Alzheimer disease β-amyloid plaque by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 1992; 89: 5462-5466.
59. 1 or bombesin receptors. Neuroreport 1992; 3: 1131-1134.
60. Shearman M S. Cellular MTT reduction distinguishes the mechanism of action of β-amyloid from that of tachykinin receptor peptides. Neuropeptides 1996; 30: 125-132.
61. Benveniste E N. Inflammatory cytokines within the central nervous system: sources, function and mechanism of action. Am J Physiology 263 (1992) C1-C16.
62. 1 type (substance P) coupled positively with phospholipase C on cortical astrocytes from the newborn mouse in primary culture. J Neurochemistry 1989; 52 1913-1918.
63. Hartung H P, Heininger K, Schafer B, Toyka K V. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. FASEBJ 1988; 2: 48-51.
64. Wienrich M, Kettenman H. Activation of substance P receptors leads to membrane potential responses in cultured astrocytes. Glia 1989; 2: 155-160.
65. Martin F C, Charles A C, Sanderson M J, Merrill J E. Substance P stimulates IL-1 production by astrocytes via intracellular calcium. Brain Res 1992; 599: 13-18.
66. Mantyh P W, Johnson D J, Boehmer C G, et al. Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci USA 1989; 86: 5193-5197.
67. Lin R C S. Reactive astrocytes express substance P immunoreactivity in the adult forebrain after injury. Neuroreport 1995; 7: 310-312.
68. Kostyk S K, Kowall N W, Hauser S L. Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Res 1989; 504: 284-288.
69. Lee C M, Kum W, Cockram C S, Teoh R, Young J D. Functional Substance P receptors on a human astrocytoma cell line (U 373 MG). Brain Res 1989; 488: 328-331.
70. Johnson C L, Johnson C G. Characterization of receptors for substance P in human astrocytoma cells: radioligand binding and inositol phosphate formation. J Neurochemistry 1992; 58: 471-477.
71. Heuillet E, Menager J, Fardin V, et al. Characterization of a human NK1 tachykinin receptor in the astrocytoma cell line U 373 MG. J Neurochemistry 1993; 60: 868-876.
72. 1 receptor antagonists of substance P and septide-induced IL-6 release from U373 MG human astrocytoma cell line. Neurosci Letters 1994; 171: 221-224.
73. Henning I M, Laissue J A, Horisberger U, Reubi J C. Substance P receptors in human primary neoplasms: tumoral and vascular localizations. Int J Cancer 1995; 61: 786-792.
74. Luo W, Sharif T F, Sharif M. Substance P induced mitogenesis in human astrocytoma cells correlates with activation of the mitogen-activated protein kinase signalling pathway. Cancer Res 1996; 56: 4983-4991.
75. Kennedy PGE, Rodgers J, Jennings F W, Murray M, Leeman S E, Burke J M. A substance P antagonist, RP 67580 ameliorates a mouse meningoencephalic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 1997; 94: 4167-4170.
76. Unger Th, Carolus W S, Demmert G, et al. Substance P induces a cardiovascular defense reaction in the rat: pharmacological characterization. Circ Res 1988; 63: 812-818.
77. Itoi K, Tschope C, Jost N, et al. Identification of the central tachykinin receptor subclass involved in substance P-induced cardiovascular and behavioral responses in conscious rats. Eur J Pharmacol 1992; 219: 435-444.
78. 1 receptor. Regul Peptides 1993; 46: 293-296.
79. 1 receptor antagonist RP67580 on central cardiovascular and behavioral effects of substance P, neurokinin A and neurokinin B. Br J Pharmacol 1995; 114: 1310-1316.
80. Culman J, Klee S, Ohlendorf C, Unger T. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress. J Pharmacol Exp Ther 1997; 280: 238-246.
81. Kalia M, Fuxe K, Hokfelt T, et al. Distribution of neuropeptide immunoreactive nerve terminals within the subnuclei of the tractus solitarius of the rat. J Comp Neurology 1984; 222: 409-420.
82. Lindefors N, Yamamoto Y, Pantaleo T, Lagercrantz H. Brodin E, Ungerstedt U. In vivo release of substance P in nucleus tractus solitarius increases during hypoxia. Neurosci Letters 1986; 69: 94-97.
83. 1 receptor mediation of the vasodepressor effects of substance P in the nucleus of the tractus solitarius. J Pharmacol Exp Ther 1995; 273: 617-623
84. Martini F, Reynaud J C, Puizillout J J. Effect of substance P on cardiovascular regulation in the rabbit. J Autonom Nervous System 1995; 51: 143-152.
85. Chen Z, Hedner J, Hedner T. Local effects of Substance P on respiratory regulation in the rat medulla oblongata. J Appl Physiology 1990; 68: 693-697.
86. Rampin O, Pierrefiche O, Denavit-Saubié M. Effects of serotonin and substance P on bulbar respiratory neurons in vivo. Brain Res 1993; 622: 185-190.
87. Srinivasan M, Goiny M, Pantaleo T, et al. Enhanced in vivo release of substance P in the nucleus tractus solitarii during hypoxia in the rabbit: role of peripheral input. Brain Res 1991; 546: 211-218.
88. Yamamoto Y, Onimaru H, Homma I. Effect of substance P on respiratory rhythm and pre-inspiratory neurons in the ventrolateral structure of rostral medulla oblongata: an in vivo study. Brain Res 1992; 599: 272-278.
89. Monteau R, Ptak K. Broquere N, Hilaire G. Tachykinins and central respiratory activity: an in vitro study on the newborn rat. Eur J Pharmacol 1996; 314: 41-50.
90. Yamazoe M, Shiosaka S, Shibasaki T, et al. Distribution of six neuropeptides in the nucleus tractus solitarii of the rat: an immunohistochemical analysis. Neuroscience 1984; 13: 1243-1266
91. Helke C J, Shults C A, Chase T N, O'Donohue T L. Autoradiographic localization of substance P receptors in rat medulla: effect of vagotomy and nodose ganglionectomy. Neuroscience 1984; 12: 215-223.
92. Ladic L A, Buchan A M J. Association of substance P and its receptor with efferent neurons projecting to the greater curvature of the rat stomach. J Autonom Nervous System 1996; 58: 25-34.
93. Boissonade F M, Davison J S. Fos induced by emetic stimuli correlates with substance P immunoreactivity in the ferret brainstem. J Physiology 1997; 499: 106P.
94. Gillis R A, Heike C J, Hamilton B L, Norman W P, Jacobowitz D M. Evidence that SP is a neurotransmitter of baro- and chemoreceptor afferents in nucleus tractus solitarius. Brain Res 1980; 181: 476-481.
95. Segu L, Lanoir J, Puizillout J J. Up-regulation of SP binding sites in the vagus nerve projection area of the cat brainstem after nodosectomy. A quantitative autoradiographic study. J Chem Neuroanatomy 1991; 4: 447-459.
96. Martini-Luccarini F, ReynaudJ C, Puizillout J J. Effects of tachykinins on identified dorsal vagal neurons: an electrophysiological study in vitro. Neuroscience 1996; 71: 119-131.
97. 1 receptor antagonist, CP 99994 in ferrets. Eur J Pharmacol 1993; 249: R3-R4.
98. 1 receptor antagonist, CP 99994 attenuates cisplatin-induced emesis in the ferret. Eur J Pharmacol 1993; 250: R5-R6.
99. 1 receptor antagonists is mediated centrally in the ferret. Br J Pharmacol 1994; 112: 516P.
100. 1 receptor antagonist, on motion-induced emesis in Suncus murinus. Br J Pharmacol 1995; 116: 250P.
101. 1 receptor antagonist GR203040. Br J Pharmacol 1996; 116: 3158-3163.
102. 1 receptor. Br J Pharmacol 1995; 115: 84-94.
103. 1 receptor antagonist, in ferrets. Eur J Pharmacol 1996; 306: 181-185.
104. Andrews P, Torii Y, Saito H, Matsuki N. The pharmacology of the emetic response to upper gastrointestinal tract stimulation in Suncus murinus. Eur J Pharmacol 1996; 307: 305-313.
105. 1 receptor, antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 1996; 8: 1121-1129.
106. 1 receptor antagonists. Eur J Pharmacol 1997; 326: 201-209.
107. 1 receptor antagonist CP 99994 in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol 1996; 119: 931-936.
108. 1 receptor antagonist PD 154075 blocks cisplatin-induced delayed emesis in the ferret. Eur J Pharmacol 1997; 321: 209-216.
109. Lucot J B, Obach R S, McLean S, Watson J W. The effect of CP 99994 on the responses to provocative motion in the cat. Br J Pharmacol 1997; 120: 116-120.
110. Buck S H, Heike C J, Burcher E, Shults C A, O'Donahue T L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 1986; 7: 1109-1120.
111. Yashpal K, Dam T V, Quirion R. Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord. Brain Res 1990; 506: 259-266.
112. 1 receptor: characterization and localization in the spinal cord. Neuroreport 1992; 3: 1073-1076.
113. Nakaya Y, Kaneko T, Shigemoto R, Nakanishi S, Mizuno N. Immunohistochemical localization of substance P receptor in the central nervous system of the adult rat. J Comp Neurology 1994; 347: 249-274.
114. 1 receptor in the dorsal horn of the rat indicates that substance P does not have a functional role on the substantia gelatinosa (lamina II) neurons. J Neurosci 1994; 14: 7655-7664.
115. 1 receptors. Neuroscience 1995; 3: 597-608.
116. 1 receptors on lumbar spinothalamic neurons in the rat. Neuroscience 1996; 72: 255-263.
117. Ma W, Ribeiro DaSilva A, De Koninck Y, Radhakrishnan V, Henry JL, Cuello A C. Quantitative analysis of SP-immunoreactive boutons on physiologically-characterized dorsal horn neurons in the cat lumbar spinal cord. J Comp Neurology 1996; 376: 45-64.
118. Yashpal K, Dam T V, Quirion R. Effects of dorsal rhizotomy on neurokinin receptor subtypes in the rat spinal cord: a quantititave autoradiographic study. Brain Res 1991; 552: 240-247.
119. 3, NMDA and 5HT1a receptor binding autoradiography. J Comp Neurology 1995; 361: 633-644.
120. Kuwahara H, Sakurada T, Sakurada S, et al. Behavioural effects of intrathecally injected tachykinins in rats with peripheral nerve transection. Naunyn Schmiedeberg's Arch Pharmacology 1987; 336: 656-660.
121. 125I] SP binding in rat spinal cord following unilateral adjuvant-induced peripheral inflammation. Neuroscience 1994; 57: 394-409.
122. Hanesch U, Blecher F, Stiller R U, Emson P C, Schaible H G, Heppelmann B. The effect of unilateral inflammation at the rat's ankle joint on the expression of preprotachykinin A mRNA and preprosomatostatin mRNA in dorsal root ganglion cells - a study using non radioactive in situ hybridization. Brain Res 1995; 700: 279-284.
123. Schafer M K H, Nohr D, Krause J E, Weihe E. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurones. Neuroreport 1993; 4: 1007-1010.
124. 3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J Neurosci 1994; 14: 712-720.
125. Abbadie C, Brown J L, Mantyh P W, Basbaum A I. Spinal cord substance P receptor immunoreactivity increases in both inflammatory and nerve injury models of persistent pain. Neuroscience 1996; 70: 201-209
126. Yashpal K, Kar S, Quirion S, Hui Chan C W Y, Henry J L. Noxious stimulation decreases substance P binding in rat spinal dorsal horn: competition by endogenous ligand? Neuroreport 1994; 5: 2101-2104.
127. Mantyh P W, DeMaster E, Malhotra A, et al. Receptor endocytosis and dendrite reshaping in spinal neurons after somatosensory stimulation. Science 1995; 268: 1629-1632.
128. 1 receptor antagonist, LY306740 blocks nociception-induced increases in dorsal horn NK1 receptor gene expression. Mol Pharmacol 1996; 50: 1189-1199.
129. Xu X J, Dalsgaard C J, Wiesenfeld-Hallin Z. Intrathecal CP 96345 blocks reflex facilitation induced in rats by substance P and C-fiber conditioning stimulation. Eur J Pharmacol 1992; 216: 337-344
130. Xu X J, Dalsgaard C J, Wiesenfeld-Hallin Z. Spinal substance P and NMDA receptors are co-activated in the induction of central sensitization of the nociceptive flexor reflex. Neuroscience 1992; 51: 641-648.
131. 1 receptor antagonist on facilitation of a nociceptive spinal flexion reflex in the rat. Br J Pharmacol 1993; 109: 713-718.
132. Ma Q P, Woolf C J. Involvement of neurokinin receptors in the induction but not the maintenance of mechanical allodynia in rat flexor motorneurones. J Physiology 1995; 486: 769-777.
133. Parsons A M, Honda C N, Jia Y P, et al. Spinal NK1 receptors contribute to the increased excitability of the nociceptive flexor reflex during persistent peripheral inflammation. Brain Res 1996; 739: 263-275.
134. 1 receptor antagonist RP 67580 attenuates progressive hypersensitivity of flexor reflex during experimental inflammation in rats. Eur J Pharmacol 1997; 322: 165-171.
135. 1 tachykinin receptors and prolonged, stimulus-evoked alterations in the excitability of withdrawal reflexes in the decerebrated and spinalized rabbit. Neuroscience 1995; 66: 673-683.
136. Houghton A K, Gorringe C M F, Clarke R W. Tachykininergic tone in the spinal cord of the rabbit: dependence on nociceptive input arising from invasive surgery. Neuroscience 1995; 69: 241-248.
137. Kream R M, Kato T, Shimonaka H, Marchand J E, Wurm W H. Substance P markedly potentiates the antinociceptive effects of morphine sulphate administered at the spinal level. Proc Natl Acad Sci USA 1993; 90: 3564-3568.
138. Ribeiro da Silva A, De Koninck Y, Cuello A C, Henry J L Enkephalin-immunoreactive nociceptive neurons in the cat spinal cord. Neuroreport 1992; 3: 25-28.
139. Ma W, Ribeiro Da Silva A, De Koninck Y, Radhakrishnan V, Cuello A C, Henry J L Substance P and enkephalin immunoreactivities in axonal boutons presynaptic to physiologically identified dorsal horn neruons. An ultrastructural multiple-labelling study in the cat. Neuroscience 1997; 77: 793-811.
140. Yashpal K, Pitcher G M, Henry J L. Noxious peripheral stimulation produces antinociception mediated via substance P and opioid mechanisms in the rat tail flick test. Brain Res 1995; 674: 97-103.
141. Yanagisawa M, Otsuka M, Konishi S, Akagi H, Folkers K, Rosell S. A substance P antagonist inhibits a slow reflex response in the spinal cord of the newborn rat. Acta Physiol Scand 1982; 116: 109-112.
142. Akagi H, Konishi S, Otsuka M, Yanagisawa M. The role of substance P as a neurotransmitter in the reflexes of slow time courses in the neonatal rat spinal cord. Br J Pharmacol 1985; 84: 663-673.
143. Otsuka M, Yanagisawa M. Effect of a tachykinin antagonist on a nociceptive reflex in the isolated spinal cord-tail preparation of the newborn rat. J Physiology 1988; 395: 255-270.
144. Guo J Z, Yoshioka K, Yanagisawa M, Hosoki R, Hagan R M, Otsuka M. Depression of primary afferent-evoked responses by GR71251 in the isolated spinal cord of the neonatal rat. Br J Pharmacol 1993; 110: 1142-1148.
145. 1 receptor antagonist, in the isolated spinal cord of the neonatal rat. Eur J Pharmacol 1995; 281: 49-54.
146. 1 receptor antagonist, on a primary afferent-evoked response of ventral roots in the neonatal spinal cord. Br J Pharmacol 1994; 113: 1141-1146.
147. 2 receptor activation to high threshold afferent fibre evoked ventral root responses in the rat spinal cord in vitro. Brain Res 1993; 625: 100-108.
148. Nagy I, Maggi C A, Dray A, Woolf C J, Urban L. The role of neurokinins and NMDA receptors in synaptic transmission from capsaicin-sensitive primary afferents in the rat spinal cord in vitro. Neuroscience 1993; 52: 1029-1037
149. 2 receptors contribute to C-fibre evoked slow potentials in the spinal cord. Neuroreport 1994; 5: 2105-208.
150. Fox A J, Naeem S, Patel I A, Walpole C, Dray A, Urban L. Receptors mediating tachykinin-evoked depolarizations of neurons in the neonatal rat spinal cord. Acta Acad Sci Hung; in press.
151. 1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J Neurosci 1994; 14: 3672-3687
152. Kurihara T, Yoshioka K, Otsuka M. Tachykininergic slow depolarization of motorneurones evoked by descending fibres in the neonatal rat spinal cord. J Physiology 1995; 485: 787-796.
153. Radhakrishnan V, Henry J L Novel substance P antagonist CP 96345 blocks responses of cat spinal dorsal horn neurons to noxious cutaneous stimulation and to substance P. Neurosci Letters 1991; 132: 39-43.
154. De Koninck Y, Henry J L. Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc Natl Acad Sci USA 1991; 88: 11344-11348.
155. De Koninck Y, Ribeiro Da Silva A, Henry J L, Cuello A C. Spinal neurons exhibiting a specific nociceptive response receive abundant substance P-containing synaptic contacts. Proc Natl Acad Sci USA 1992; 89: 5073-5077.
156. 1 receptor antagonists CP 96345 and CP 99994 but not by CP 96344. Neuroscience 1995; 64: 943-958.
157. 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci Letters 1993; 157: 149-152.
158. Toda T, Hayashi H. The inhibitory effect of substance P antagonist, CP 96345, on the late discharges of nociceptive neurons in the rat superficial spinal dorsal horn. Neurosci Letters 1993; 158: 36-38.
159. 1 receptors in the responses of rat dorsal horn neurons to noxious but not to innocuous mechanical stimuli applied to the knee joint. Brain Res 1994; 666: 207-215.
160. 1 receptors in the hyperexcitability of dorsal horn neurons during development of acute arthritis in rat's knee joint. J Neurophysiology 1995; 73: 1574-1583.
161. Hoheisel U, Sander B, Mense S. Myositis-induced reorganization of the rat dorsal horn: effects of spinal superfusion with antagonists to neurokinin and glutamate receptors. Pain 1997; 69: 219-230.
162. 1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin. J Neurophysiology 1994; 72: 464-1475.
163. 1 receptor-dependent component of the slow excitation recorded intracellularly from rat motorneurons following dorsal root stimulation. Eur J Neuroscience 1995; 7: 2409-2417.
164. Baranauskas G, Nistri A. NMDA receptor-independent mechanisms responsible for the rate of rise of cumulative depolarization evoked by trains of dorsal root stimuli on rat spinal motorneurons. Brain Res 1996; 738: 329-332.
165. Noguchi K, Kawai Y, Fukuoka T, Senba E, Miki K. Substance P induced by peripheral nerve injury in primary afferent sensory neurons and its effects on dorsal column nucleus neurons. J Neurosci 1995; 15: 7633-7643.
166. 1 receptor activation and interactions with NMDA receptors to inflammatory evoked spinal c-fos expression. J Neurophysiology 1996; 76: 1817-1827.
167. 1 receptor to formalin-induced c-fos expression in the rat spinal dorsal horn. Neurosci Letters 1997; 221: 105-108.
168. Battaglia G, Rustioni A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the rat and monkey. J Comp Neurology 1988; 277: 297-312.
169. De Biasi S, Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc Natl Acad Sci USA 1988; 85: 7820-7824.
170. Merighi A, Polak J M, Theodosis D T. Ultrastructural visualization of glutamate and aspartate immunoreactivities in the rat dorsal horn with special reference to the colocalization of glutamate, SP and CGRP. Neuroscience 1991; 40: 67-80.
171. Randic M, Hecimovic H, Ryu P D. Substance P modulates glutamate-induced currents in acutely isolated rat sinal dorsal horn neurons. Neurosci Letters 1990; 117: 74-80.
172. Rusin K I, Ryu P D, Randic M. Modulation of excitatory aminoacids responses in rat dorsal horn neurons by tachykinins. J Neurosci 1992; 68: 265-286.
173. Rusin K I, Bleakman D, Chard P S, Randic M, Miller R J. Tachykinins potentiate NMDA responses in acutely isolated neurons from the dorsal horns. J Neurochemistry 1993; 60: 952-960.
174. 1 receptor agonist facilitation of NMDA receptor agonist-evoked activity in rat dorsal horn neurons. Brain Res 1997; 744: 235-245.
175. Dougherty P M, Palecek J, Zorn S, Willis W D. Combined application of excitatory aminoacids and substance P produces long lasting changes of primate spinothalamic tract neurons. Brain Res Reviews 1993; 18: 227-246.
176. Urban L, Naeem S, Patel I A, Dray A. Tachykinin induced regulation of excitatory aminoacid responses in the rat spinal cord in vitro. Neurosci Letters 1994; 168: 185-188.
177. Cumberbatch M J, Chiz B A, Headley P M. Modulation of excitatory aminoacid responses by tachykinins and selective tachykinin receptor agonists in the rat spinal cord. Br J Pharmacol 1995; 115: 1005-1012.
178. 2 receptors in the rat spinal cord. Br J Pharmacol 1995; 115: 1013-1019.
179. Seguin L, Millan M J. The glicine B receptor partial agonist (+)-HA 966, enhances induction of antinociception by RP 67580 and CP 99994. Eur J Pharmacol 1994; 253: R1-R3.
180. Juranek I, Lembeck F. Evidence for the participation of glutamate in reflexes involving afferent, substance P-containing nerve fibres in the rat. Br J Pharmacol 1996; 117: 71-78.
181. Lembeck E Zur Frage der zentralen Ubertragung afferenter Impulse III. Mitteilung. Das Vorkommen und die Bedeutung der Substanz P in den dorsalen Wurzeln des Ruckenmarks. Arch Exp Pathol Pharmakol 1953; 219: 197-213.
182. Hylden J L K, Wilcox G L. Intrathecal substance P elicits a caudally directed biting and scratching behaviour. Brain Res 1981; 217: 212-215.
183. Piercey M F, Dobry P J K, Schroeder L A, Einspahr F J. Behavioral evidence that substance P may be a spinal cord sensory neurotransmitter. Brain Res 1981; 210: 407-412.
184. Laneuville O, Dorais J, Couture R. Characterization of the effects produced by neurokinins and three agonists selective for neurokinin receptor subtypes in a spinal nociceptive reflex of the rat. Life Sciences 1988; 42: 1295-1305.
185. 2 receptors in a spinal nociceptive reflex in the rat. Eur J Pharmacol 1993; 232: 255-261.
186. 1 tachykinin receptors in thermonociception: effect of (±)CP 96345 a nonpeptide substance P antagonist on the hot plate test in mice. Neurosci Letters 1991; 129: 299-302.
187. 1 selective antagonist, CP 96345: antinociception in the absence of motor disfunction. Life Sciences 1991; 49: 1955-1963.
188. Yamamoto T, Yaksh T L. Effects of intrathecal capsaicin and an NK1 antagonist, CP 96345, on the thermal hyperalgesia observed following unilateral constriction of the sciatic nerve in the rat. Pain 1992; 51: 329-334.
189. Nagahisa A, Kanai Y, Suga O, et al. Antinflammatory and analgesic activity of a nonpeptide substance P receptor antagonist. Eur J Pharmacol 1992; 217: 191-195.
190. 1 receptor antagonist, in the mouse formalin and capsaicin test. Neurosci Letters 1993; 151: 142-145.
191. 1 receptor antagonist, on the formalin test in the rat. Neurosci Letters 1993; 161: 57-59.
192. Yashpal K, Radhakrishnan V, Coderre T J, Henry J L. CP96345 but not its stereoisomer CP 96344 blocks the nociceptive responses to intrathecally administered substance P and to noxious thermal and chemical stimuli in the rat. Neuroscience 1993; 52: 1039-1047.
193. Amann R, Schuligoi R, Holzer P, Donnerer J. The nonpeptide NK1 receptor antagonist SR 140333 produces long lasting inhibition of neurogenic inflammation but does not influence acute chemo- or thermonociception in rats. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 352: 201-205.
194. 2 receptors in a spinal nociceptive reflex in the rat. Eur J Pharmacol 1993; 232: 255-261.
195. 1 receptor antagonists: nonspecific effects of racemic RP 67580. Br J Pharmacol 1993; 110: 1607-1613.
196. 1 receptor antagonist, CP 99994 in antinociceptive tests in rat, mouse and gerbil. Eur J Pharmacol 1994; 271: 481-487.
197. 1 antagonist, RP 67580 inhibiting chemonociception. Br J Pharmacol 1995; 115: 486-490.
198. 1 receptor antagonist, CP 99994 in conscious gerbils. Br J Pharmacol 1995; 116: 1937-1943.
199. 1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol 1996; 117: 196-202.
200. 1 receptor antagonist L733060 in gerbils. Pain 1996; 67: 189-195.
201. 2 receptor antagonists: a comparison to other classes of aninociceptive agent. Pain 1995; 61: 325-343.
202. Maggi C A. Tachykinins as peripheral modulators of primary afferent nerves and visceral sensitivity. Pharmacol Res 1997; 36: 153-169.
203. Carlton S M, Zhou S, Coggeshall R E. Localization and activation of substance P receptors in unmyelinated axons of rat glabrous skin. Brain Res 1996; 734: 103-108.
204. Yamashita T, Cavanaugh J M, Ozaktay A C, Avramov A I, Getchell T V, King A I. Effect of substance P on mechanisensitive units of tissues around and in the lumbar facet joint. J Orthopaedic Res 1993; 11: 205-214.
205. Heppelmann B, Pawlak M. Sensitization of articular afferents in normal and inflamed knee joints by substance P in the rat. Neurosci Letters 1997; 223: 97-100.
206. 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation. Br J Pharmacol 1997; 120: 1263-1273.
207. Neumann S, Doubell T P, Leslie T, Woolf C J. Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons. Nature 1996; 384: 360-364.
208. 125I-Bolton-Hunter labeled substance P binding sites in rat spinal cord. J NeuroSci 1985; 5: 1293-1299.
209. Charlton C G, Heike C J. Autoradiographic localization and characterization of spinal cord substance P binding sites: high densities in sensory, autonomic, phrenic, and Onuf's motor nuclei. J Neurosci 1985; 5: 1653-1661.
210. Buck S H, Helke C J, Burcher E, Shults C A, O'Donahue T L. Pharmacologic characterization and autoradiographic distribution of binding sites for iodinated tachykinins in the rat central nervous system. Peptides 1986; 7: 1109-1120.
211. Yashpal K, Dam T V, Quirion R. Quantitative autoradiographic distribution of multiple neurokinin binding sites in rat spinal cord. Brain Res 1990; 506: 259-266.
212. 1 receptor on different subpopulations of sympathetic preganglionic neurons in the rat. J Comp Neurology 1996; 374: 370-386.
213. Llewellyn-Smith I J, Martin C L, Minson J B, et al. NK1 receptor immunoreactive sympathetic preganglionic neurons: target specificity and ultrastructure. Neuroscience 1997; 77: 1137-1149.
214. 1 receptor mechanism. Naunyn-Schmiedeberg's Arch Pharmacology 1988; 338: 649-654.
215. Pham T M, Couture R. Inhibitory action of (±)CP 96345 on the cardiovascular response to intrathecal substance P and neuropeptide K in the conscious freely moving rat. Naunyn-Schmiedeberg's Arch Pharmacology 1993; 347: 34-41.
216. Poulat P, De Champlain J, Couture R. Cardiovascular responses to intrathecal neuropeptide g in conscious rats: receptor characterization and mechanism of action. Br J Pharmacol 1996; 117: 250-257.
217. 1 receptor antagonist. Am J Physiology 1992; 73: 1389-1395.
218. Hill J M, Pickar J G, Kaufman M P. Blockade of non-NMDA receptors attenuates reflex pressor responses to static contraction. Am J Physiology 1994; 266: H1769-H1776.
219. 1 receptors in cardiovascular responses to chemical stimulation of the gallbladder. Am J Physiology 1995; 268: H526-H530.
220. Maggi C A. The role of peptides in the regulation of micturition reflex: an update. Gen. Pharmacol 1991: 22 1-43.
221. 1 receptor antagonist, CP 96345, inhibits the micturition reflex in the rat. Regul Peptides 1993; 46: 392-395.
222. Lecci A, Giuliani S, Garret C, Maggi C A. Evidence for a role of tachykinins as sensory transmitters in the activation of micturition reflex. Neuroscience 1993; 54: 827-837
223. Lecci A, Giuliani S, Maggi C A. Effect of the NK1 receptor antagonist GR 82334 on reflexly-induced bladder contractions. Life Sci 1992; 51: PL277-280.
224. 2 antagonists on xylene-induced cystitis in rat. Neuropeptides 1993; 24: 199.
225. Ishizuka O, Igawa Y, Lecci A, Maggi C A, Mattiasson A, Andersson K E. Role of intrathecal tachykinins for micturition in unanaesthetized rats with and without bladder outlet obstruction. Br J Pharmacol 1994; 113: 111-116.
226. Morikawa K, Ichihashi M, Kakiuchi M, et al. Effects of various drugs on bladder function in conscious rats. Japan J Pharmacology 1989; 50: 369-376.
227. Muhlhauser M A, Thor K. Vesicoanal reflex activity in the rat: a model of urinary bladder irritation. Soc Neurosci Abstr 1992; 18: 500.
228. 1 antagonist, CP 96345, on visceral nociceptive activity and non-nociceptive bladder activity in rats. Regul Peptides 1992; Suppl. 1: S80.
229. Geppetti P, Tramontana M, Patacchini R, Del Bianco E, Santicioli P, Maggi C A. Neurochemical evidence for the activation of the efferent function of capsaicin-sensitive nerves by lowering of the pH in the guineapig urinary bladder. Neurosci Letters 1990; 114: 101-106.
230. Birder L A, Roppolo J R, Ladarola M J, De Groat W C. c-fos as a marker for subsets of visceral second order neurons in the rat lumbosacral spinal cord. Soc Neurosci Abstr 1990; 16: 703.
231. Lecci A, Giuliani S, Meini S, Maggi C A. Pharmacological analysis of the local and reflex responses to bradykinin on rat urinary bladder motility in vivo. Br J Pharmacol 1995; 114: 708-714.
232. 2) receptor antagonists. J Pharmacol Exp Ther 1996; 276: 212-218.
233. 1 receptors modulate the afferent arm of the micturition reflex through capsaicin-sensitive primary afferent neurons. J Autonom Nerv Syst 1993; 43 (Suppl.): 90.
234. Ishizuka O, Mattiasson A, Andersson K E. Effects of neurokinin receptor antagonists on L-DOPA induced bladder hyperactivity in normal conscious rats. J Urology 1995; 154: 1548-1551.
235. Furness J B, Papka R E, Della N G, Costa M, Eskay R L. Substance P-like immunoreactivity in nerves associated with the vascular system in guinea-pigs. Neuroscience 1982; 7 447-459.
236. Barja F, Mathison R, Huggel H. SP-containing nerve fibers in large peripheral blood vessels of the rat. Cell Tissue Res 1983; 229: 411-422.
237. Wharton J, Gulbenkian S. Peptides in the mammalian cardiovascular system, in J M. Polak (Ed), Regulatory Peptides, Birkhauser Basel, 1989; pp 292-316.
238. Maggi C A. Tachykinins and CGRP as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiology 1995; 45: 1-98.
239. Loesch A, Burnstock G. Ultrastructural localization of serotonin and substance P in vascular endothelial cells of rat femoral and mesenteric arteries. Anat Embryol 1988; 178: 137-142.
240. Linnik M D, Moskowitz M A. Identification of immunoreactive substance P in human and other mammalian endothelial cells. Peptides 1989; 10: 957-962.
241. Ralevic V, Milner P, Hudlicka O, Kristek F, Burnstock G. Substance P is released from the endothelium of normal and capsaicin-treated rat hind limb vasculature in vivo, by increased flow. Circ Res 1990; 66: 1178-1183.
242. 125I] Bolton Hunter SP binding to dog carotid artery. Eur J Pharmacol 1986; 124: 377-378.
243. Stephenson J A, Summers R J. Autoradiographic analysis of receptors on vascular endothelium. Eur J Pharmacol 1987; 134: 35-43.
244. Sertl K, Wiedermann C J, Kowalski M L, et al. Substance P: the relationship between receptor distribution in rat lung and the capacity of substance P to stimulate vascular permeability. Am Rev Resp Dis 1988; 138: 151-159.
245. Saito R, Konishi H, Takano Y, et al. Characterization of tachykinin receptors in endothelial cells of porcine artery. Neurosci Letters 1990; 110: 337-342.
246. 1 receptors for substance P are expressed by human vascular endothelium. J Exp Med 1993; 177: 1269-1276.
247. 1) recepytor immunoreactivity on endothelial cells of the rat tracheal mucosa. Am J Physiology 1996; 270: L404-L413.
248. Ziche M, Morbidelli L, Pacini M, Geppetti P, Alessandri G, Maggi C A. Substance P stimulates neovascularization in vivo and proliferation of cultured endothelial cells. Microvasc Res 1990; 40: 264-278.
249. 1 receptor mediated activity. Life Sci Pharmacol Letters 1991; 48 PL-7-PL-11.
250. Ziehe M, Morbidelli L, Parenti A, Amerini S, Granger H J, Maggi C A. Substance P increases cyclic GMP levels on coronary postcapillary venular endothelial cells. Life Sci Pharmacol Letters 1993; 53: PL229-PL234.
251. Ziehe M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994; 94: 2036-2044.
252. 1 or interleukin 1 receptor antagonists. Br J Pharmacol 1993; 110: 43-49.
253. Walsh D A, Hu D E, Mapp P I, Polak J M, Blake D R, Fan T D P. Innervation and neurokinin receptors during angogenesis in the rat sponge granuloma. Histochem J 1996; 28: 759-769.
254. Khalil Z, Helme R. Sensory peptides as neuromodulators of wound healing in aged rats. J Gerontology 1996; 51A: B354-B361.
255. Hennig I M, Laissue J A, Horisberger U, Reubi J C. Substance P receptors in human primary neoplasms: tumoral and vascular localizations. Int J Cancer 1995; 61: 786-792.
256. Reubi J C, Mazzucchelli L, Hennig I, Laissue J A. Local upregulation of neuropeptide receptors in host blood vessels around human colorectal cancers. Gastroenterology 1996; 110: 1719-1726.
257. Matis W L, Lavker R M, Murphy G S. Substance P induces the expression of an endothelial-leukocyte adhesion molecule by microvascular endothelium. J Invest Dermatol 1990; 94: 492-495.
258. Nakagawa N, Sano H, Iwamoto I. Substance P induces the expression of intercellular adhesion molecule on vascular endothelial cell and enhances neutrophil transendothelial migration. Peptides 1995: 16: 721-725.
259. Pacicca C, Von der Weid P Y, Beny J L. Effects of nitro-L-arginine on endothelium-dependent hyperpolarizations and relaxations of pig coronary arteries. J Physiol 1992; 457: 247-256.
260. Zhang G, Yamamoto Y, Miwa K, Suzuki H. Vasodilatation induced by substance P in guinea-pig carotid arteries. Am J Physiology 1994; 266: H1132-H1137.
261. Kuroiwa M, Aoki H, Kobayashi S, Nishimura J, Kanaide H. Mechanism of endothelium-dependent relaxation induced by substance P in the coronary artery of the pig. Br J Pharmacol 1995; 116: 2040-2047
262. D'Orleans-Juste P, Dion S, Drapeau G, Regoli D. Different receptors are involved in the endothelium-mediated relaxation and the smooth muscle contraction of the rabbit pulmonary artery in response to substance P and related neurokinins. Eur J Pharmacol 1986; 125: 37-44.
263. Maggi C A, Patacchini R, Perretti F, Tramontana M, Manzini S, Geppetti P, Santicioli P. Sensory nerves, vascular endothelium and neurogenic relaxation of the guinea-pig isolated pulmonary artery. Naunyn Schmiedeberg's Arch Pharmacol 1990; 342: 78-84.
264. 1 receptors and TXA2. Br J Pharmacol 1995; 115: 1215-1220.
265. 1 receptors mediate both vasoconstrictor and vasodilator responses in the rabbit isolated jugular vein. Eur J Pharmacol 1995; 283: 233-240.
266. Franco-Cereceda A. Resiniferatoxin, capsaicin and CGRP-evoked porcine coronary vasodilatation is independent of EDRF mechanisms but antagonized by CGRP(8-37). Acta Physiol Scand 1991; 143 331-337.
267. Li Y, Duckles S P. Effect of endothelium on the actions of sympathetic and sensory nerves in the perfused rat mesentery. Eur J Pharmacol 1992; 210 23-30.
268. Stubbs C M, Waldron G J, Connor H E, Feniuk W. Characterization of the receptor mediating relaxation to substance P in canine middle cerebral artery: no evidence for involvement of substance P in neurogenically mediated relaxation. Br J Pharmacol 1992; 105: 875-880.
269. Persson M G, Hedqvist P, Gustafsson L E. Nerve-induced tachykinin-mediated vasodilatation in skeletal muscle is dependent on nitric oxide formation. Eur J Pharmacol 1991; 205: 295-301.
270. Galligan J J, Jiang M M, Shen K Z, Surprenant A. Substance P mediates neurogenic vasodilatation in extrinsically denervated guinea-pig submusocal arterioles. J Physiol 1990; 420: 267-280.
271. Zochodne D W, Ho L T. Influence of perivascular peptides on endoneurial blood flow and microvascular resistance in the sciatic nerve of the rat. J Physiol 1991; 444: 615-630.
272. Yonehara N, Chen J Q, Imai Y, Inoki R. Involvement of substance P present in primary afferent neurones in modulation of cutaneous blood flow in the instep of rat hindpaw. Br J Pharmacol 1992: 106 256-262.
273. Brock J W, Joshua I G. Neural release of substance P causes dilation of arterioles in rat striated muscle. Regul Peptides 1993; 43: 65-71.
274. Ferrell W R, Lockhart J C, Karimian S M. Tachykinin regulation of basal synovial blood flow. Br J Pharmacol 1997; 121: 29-34.
275. 1 receptor antagonists on vasodilatation induced by chemical and electrical activation of sensory C-fibre afferents in different organs. Acta Physiol Scand 1994; 152: 153-161.
276. 1) receptor in DOCA-salt hypertension. Hypertension 1995; 26: 1186-1189.
277. Kohlmann O, Cezaretti M L, Ginoza M, et al. Role of substance P in blood pressure regulation in salt-dependent experimental hypertension. Hypertension 1997; 29: 506-509.
278. Jancsò N, Jancso-Gabor A, SzolcsanyiJ. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol 1967; 31: 138-151.
279. Jancsò N, Jancso-Gabor A, Szolcsanyi J. The role of sensory nerve endings in neurogenic inflammation induced in human skin and in the eye and paw of the rat. Br J Pharmacol 1968; 32: 32-41
280. Maggi C A, Meli A. The sensory-efferent function of capsaicin-sensitive sensory neurons. Gen. Pharmacol 1988; 19: 1-43.
281. Lembeck F, Holzer P. Substance P as neurogenic mediator of antidromic vasodilatation and neurogenic plasma extravasation. Naunyn-Schmiedeberg's Arch Pharmacol 1979; 310: 175-183.
282. Saria A, Lundberg J M, Skofitsch G, Lembeck F. Vascular protein leakage in various tissues induced by substance P, capsaicin, bradykinin, serotonin, histamine and by antigen challenge. Naunyn-Schmiedeberg's Arch Pharmacol 1983; 324: 212-218.
283. Jacques L, Couture R, Drapeau G, Regoli D. Capillary permeability induced by intravenous neurokinins, receptor characterization and mechanism of action. Naunyn Schmiedeberg's Arch Pharmacol 1989; 340: 170-179.
284. 1 receptors. J Autonom Pharmacol 1991; 11: 267-275.
285. 1 receptors. Eur J Pharmacol 1991; 209: 277-279.
286. 2 antagonist MEN 10207. Neurosci Letters 1992; 139: 249-252.
287. Ralevic V, Khalil Z, Helme R D, Dusting G J. Role of NO in the actions of SP and other mediators of inflammation in rat skin microvasculature. Eur J Pharmacol 1995; 284: 231-239.
288. Nguyen L S, Villablanca A C, Rutledge J C. Substance P increases microvascular permeability via nitric oxide-mediated convective pathways. Am J Physiology 1995; 268: R1060-R1068.
289. 1 receptor activation in rats. J Autonom Pharmacol 1993; 13: 193-199.
290. Baluk P, Nadel J A, McDonald D. Substance P-immunoreactive sensory axons in the rat respiratory tract: a quantitative study of their distribution and role in neurogenic inflammation. J Comp Neurol 1992; 319: 586-598.
291. 1) receptor immunoreactivity on endothelial cells of the rat tracheal mucosa. Am J Physiology 1996; 270: L404-L413.
292. Lundberg J M, Franco-Cereceda A, Hua X Y, Hokfelt T, Fischer J A. Coexistence of SP and CGRP-LI in sensory nerves in relation to cardiovascular and bronchoconstrictor effects of capsaicin. Eur J Pharmacol 1985; 108: 315-319
293. Franco Cereceda A, Henke H, Lundberg J M, Petermann J B, Hokfelt T, Fischer J A. CGRP in capsaicin-sensitive SP-immunoreactive sensory neurons in animals and man: distribution and release by capsaicin. Peptides 1987; 8: 399-410
294. Hoover D B. Effects of capsaicin on release of SP-LI and physiological parameters in isolated perfused guinea-pig heart. Eur J Pharmacol 1987; 141: 489-492.
295. Franco Cereceda A, Lundberg J M. Actions of CGRP and tachykinins in relation to the contractile effects of capsaicin in the guinea-pig and rat heart in vitro. Naunyn-Schmiedeberg's Arch Pharmacol 1988; 337: 649-655.
296. Geppetti P, Maggi C A, Perretti F, Frilli S, Manzini S. Simultaneous release by bradykinin of substance P and CGRP immunoreactivities from capsaicin-sensitive structures in guinea-pig heart. Br J Pharmacol 1988; 94: 288-290.
297. Manzini S, Perretti F, De Benedetti L, Pradelles P, Maggi C A, Geppetti P. A comparison of bradykinin and capsaicin-induced myocardial and coronary effects in isolated perfused heart of guinea-pig: involvement of SP and CGRP release. Br J Pharmacol 1989; 97: 303-312.
298. Brum J M, Go V L W, Sufan Q, Lane G, Reilly W, Bove A A. Substance P distribution and effects in the canine epicardial coronary arteries. Regul Peptides 1986; 14: 41-55.
299. Hoover D B, Hancock J C. Distribution of substance P binding sites in guinea-pig heart and pharmacological effects of substance P. J Autonom Nervous System 1988; 23: 189-197
300. Smith D C, Priola D V, Blomquist T M. Substance P modulates autonomic nerve activity in canine hearts. Am J Physiol 1992; 262: H1663-H1668.
301. Priola D V, Cao X, Smith D C. Modulation of autonomie responses in normal and denervated isolated canine atria by substance P. Am J Physiology 1994; 266: H1401-H1407
302. Chiao H, Caldwell R W. Local cardiac effects of substance P: roles of acetylcholine and noradrenaline. Br J Pharmacol 1995; 114: 283-288
303. Weglicki W B, Mak I T, Phillips T M. Blockade of cardiac inflammation in Mg deficiency by substance P receptor inhibition. Circ Res 1994; 74: 1009-1013.
304. Weglicki W B, Mak I T, Stafford R E, Dickens B F, Cassidy M M, Phillips T M. Neurogenic peptides and the cardiomyopathy of magnesium deficiency: effects of substance P receptor inhibition. Mol Cell Biochemistry 1994; 130: 103-109.
305. Walsh R J, Weglicki W B, Correadearaujo R. Distribution of specific substance P binding sites in the heart and adjacent great vessels of the Wistar white rat. Cell Tissue Res 1996; 284: 495-500.
306. Kramer J H, Phillips T M, Weglicki W B. Magnesium deficiency-enhanced postischemic myocardial injury is reduced by substance P receptor blockade. J Mol Cell Cardiology 1997; 29: 97-110.
307. Ustinova E E, Bergren D, Schultz H D. Neuropeptide depletion impairs postischemic recovery of the isolated rat heart: role of substance P. Cardiovasc Res 1995; 30: 55-63.
308. Chiao H, Caldwell R W. The role of substance P in myocardial dysfunction during ischemia and reperfusion. Naunyn-Schmiedeberg's Arch Pharmacology 1996; 353: 400-407.
309. Rankin A J, Scott T M. Capsaicin-sensitive nerves influence the release of atrial natriuretic factor by atrial stretch in the rat. Regul Peptides 1990; 30: 65-76.
310. Church D J, Arkinstall S J, Vallotton M B, Chollet A, Kawashima E, Lang U. Stimulation of atrial natriuretic peptide release by neurokinins in neonatal rat ventricular cardiomyocytes. Am J Physiology 1996; 270: H935-H944.
311. Szolcsanyi J, Bartho L. Capsaicin-sensitive non-cholinergic excitatory innervation of the guinea-pig tracheobronchial smooth muscle. Neurosci Letters 1982; 34 247-250.
312. Szolcsanyi J. Tetrodotoxin-resistant noncholinergic neurogenic contraction evoked by capsaicinoids and piperine on the guinea-pig trachea. Neurosci Letters 1983; 42: 83-88.
313. Lundberg J M, Saria A. Bronchial smooth muscle contraction induced by stimulation of capsaicin-sensitive sensory neurons. Acta Physiol Scand 1982; 116 473-476.
314. Lundberg J M, Saria A. Capsaicin-induced desensitization of airway mucosa to cigarette smoke, mechanical and chemical irritants. Nature 1983; 302 251-253.
315. Maggi C A, Giachetti A, Dey R D, Said S I. Neuropeptides as regulators of airway function: with special reference to VIP and the tachykinins. Physiol Rev 1995; 75: 277-322.
316. 3H] FK888. Mol Pharmacology 1993; 44: 539-544.
317. 1 binding sites between human and guinea-pig lung. Br J Pharmacol 1994; 113: 1407-1415.
318. 1 and NK2 tachykinin receptors and changes after repeated antigen challenge in guinea-pigs. Peptides 1996; 17: 1389-1395.
319. 1) receptor immunoreactivity on endothelial cells of the rat tracheal mucosa. Am J Physiology 1996; 270: L404-L413.
320. Maggi C A, Patacchini R, Quartara L, Rovero P, Santicioli P. Tachykinin receptors in the guinea-pig isolated bronchi. Eur J Pharmacol 1991; 197 167-174.
321. Maggi C A, Patacchini R, Rovero P, Santicioli P. Tachykinin receptors and noncholinergic bronchoconstriction in the guinea-pig isolated bronchi. Am Rev Resp Dis 1991; 144: 363-367.
322. 2 receptor selective antagonist, MEN 10376. J Pharmacol Exp Therap 1991; 257: 1172-1178.
323. Ballati L, Evangelista S, Maggi C A, Manzini S. Effect of selective tachykinin receptor antagonists on capsaicin- and tachykinin-induced bronchospasm in anaesthetized guinea-pigs. Eur J Pharmacol 1992; 214: 215-221.
324. Manzini S. Bronchodilation by tachykinins and capsaicin in the mouse main bronchus. Br J Pharmacol 1992; 105: 968-972.
325. 1 receptor induces relaxation of rat trachea through release of prostaglandin E2. J Pharmacol Exp Ther 1992; 263: 767-772.
326. Saria A, Martling C R, Yan Z, Theodorsson-Norheim E, Gamse R, Lundberg J M. Release of multiple tachykinins from capsaicin-sensitive sensory nerves in the lung by bradykinin, histamine, DMPP and vagal nerve stimulation. Am Rev Resp Dis 1988; 137: 1330-1335.
327. Maggi C A, Patacchini R, Perretti F, et al. The effect of thiorphan and epithelium removal on contractions and tachykinin release produced by activation of the capsaicin-sensitive afferents in the guinea-pig isolated bronchus. Naunyn-Schmiedeberg's Arch Pharmacol 1990; 341: 74-79.
328. Belvisi M G, Patacchini R, Barnes P J, Maggi C A. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences. Br J Pharmacol 1994; 111: 103-110.
329. Szarek J L, Spurlock B. Antagonism of cholinergic nerve-mediated contractions by the sensory nerve inhibitory system in rat bronchi. J Appl Physiology 1996; 81: 260-265.
330. Webber S E. Receptors mediating the effects of substance P and neurokinin A on mucus secretion and smooth muscle tone of the ferret trachea: potentiation by an enkephalinase inhibitor. Br J Pharmacol 1989; 98: 1197-1206.
331. Rogers D F, Aursudkij B, Barnes P J. Effect of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol 1989; 174: 283-286.
332. Kuo H P, Rohde J A, Tokuyama K, Barnes P J, Rogers D F. Capsaicin and sensory neuropeptide stimulation of goblet cell secretion in guinea-pig trachea. J Physiol 1990; 431: 629-641.
333. Meini S, Mak J C W, Rohde J A L, Rogers D F. Tachykinin control of ferret airways: mucus secretion, bronchoconstriction and receptor mapping. Neuropeptides 1993; 24: 81-89.
334. Ranmarine S I, Hirayama Y, Barnes P J, Rogers D F. 'Sensory-efferent' neural control of mucus secretion: characterization using tachykinin receptor antagonists in ferret trachea in vitro. Br J Pharmacol 1994; 113: 1183-1190.
335. 1 antagonist CP 96345. Eur J Pharmacol 1991; 203: 157-158.
336. 1 receptors and smoke-induced protein extravasation in relation to its cardiovascular effects.
337. Piedimonte G, Bertrand C, Geppetti P, Snider R M, Desai M C, Nadel J A. A new NK1 receptor antagonist (CP-99994) prevents the increase in tracheal vascular permeability produced by hypertonic saline. J Pharmacol Exp Ther 1993; 266: 270-273.
338. 1 receptor antagonist, against substance P-bradykinin, and allergen-induced airway microvascular leakage and bronchoconstriction in the guinea-pig. Eur J Pharmacol 1993; 231: 31-38.
339. Ishikawa J, Ichinose M, Miura M, et al. Involvement of endogenous tachykinins in LTD4-induced airway responses. Eur Resp J 1996; 9: 486-492.
340. Buckley T L, Nijkamp F P. Mucosal exudation associated with a pulmonary delayed-type hypersensitivity reaction in the mouse, role for the tachykinins. J Immunology 1994; 153: 4169-4178.
341. Yoshihara S, Chan B, Yamawaki I, et al. Plasma extravasation in the rat trachea induced by cold air is mediated by tachykinin release from sensory nerves. Am J Respir Crit Care 1995; 151: 1011-1017
342. Ito K, Sakamoto T, Hayashi Y, et al. Role of tachykinin and bradykinin receptors and mast cells in gaseous formaldehyde-induced airway microvascular leakage in rats. Eur J Pharmacol 1996; 307: 291-298.
343. Biyah K, Molimard M, Emonds-Alt X, Advenier C. SR 140333 prevents potentiation by citric acid of plasma exudation induced by histamine in airways. Eur J Pharmacol 1996; 308: 325-328.
344. Bertrand C, Geppetti P, Baker, Yamawaki I, Nadel J A. Role of neurogenic inflammation in antigen-induced vascular extravasation in guinea-pig trachea. J Immunology 1993; 150: 1479-1485.
345. Bonham A C, Kott K S, Ravi K, Kappagoda C T, Joad J P. Substance P contributes to rapidly adapting receptor responses to pulmonary venous congestion in rabbits. J Physiology 1996; 493: 229-238.
346. Baluk P, Bertrand C, Geppetti P, McDonald D, Nadel J A. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiology 1995; 268: L263-L269.
347. Kaltreider H B, Ichikawa S, Byrd P K, et al. Upregulation of neuropeptides and neuropeptide receptors in a murine model of immune inflammation in lung parenchyma. Am J Resp Cell Mol Biol 1997; 133-144.
348. Bozic C R, Lu B, Hopken U E, Gerard C, Gerard N P. Neurogenic amplification of immune complex formation. Science 1996; 273: 1722-1725.
349. Scheerens H, Buckley T L, Muis T, Van Loveren H, Nijkamp F P. The involvement of sensory neuropeptides in toluene diisocyanate-induced tracheal hyperreactivity in the mouse airways. Br J Pharmacol 1996; 119: 1655-1671.
350. Fidone S J, Gonzalez C. Initiation and control of chemoreceptor activity in the carotid body. In: Handbook of Physiology: The Respiratory System, control of breathing. Bethesda, MD: Am Physiol Soc, 1986; III vol II; pp 247-312.
351. Lundberg J M, Hokfelt T, Fahrenkrug J, Nilsson G, Terenius L. Peptides in the cat carotid body (glomus caroticum): VIP-enkephalin- and substance P-like immunoreactivity. Acta Physiol Scand 1979; 107: 279-281.
352. Jacobowitz D M, Heike C J Localization of substance P immunoreactive nerves in the carotid body. Brain Res Bull. 1980; 5: 195-197
353. Wharton J, Polak J M, Pearse A G, et al. Enkephalin- VIP- and Substance P-like immunoreactivity in the carotid body. Nature 1980; 284: 269-271.
354. McQueen D S. Effects of substance P on carotid chemoreceptor activity in the cat. J Physiology 1980; 302: 31-47.
355. Prabhakar N R, Yamamoto Y, Runold M, Lagercrantz H, Von Euler C, Folkers K. Central and periheral effects of substance P and an adenosine analogue (L-PLA) on respiration. Neurosci Letters 1983; 14: S291.
356. Prabhakar N R, Kou Y R, Runold M. Chemoreceptor responses to substance P, Physalaemin, and eledoisin: evidence for NK1 receptors in the carotid body. Neurosci Letters 1990; 120: 183-186.
357. Prabhakar N R, Cao H, Lowe III J A, Snider R M. Selective inhibition of the carotid body sensory response to hypoxia by the substance P receptor antagonist CP 96345. Proc Natl Acad Sci USA 1993; 90: 10041-10045.
358. 1 receptor antagonist, CP 96345. J Appl Physiology 1994; 76: 1528-1532.
359. Bartho' L, Holzer P. Search for a physiological role of substance P in gastrointestinal motility. Neuroscience 1985; 16: 1-32.
360. Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part I. Expression release and motor function. Pharmacol Ther 1997; 73: 173-218.
361. Holzer P, Holzer-Petsche U. Tachykinins in the gut. Part II. Roles in neural excitation, secretion and inflammation. Pharmacol Ther 1997; 73: 219-264.
362. Burcher E, Shults C W, Buck S H, Chase T N, O' Donahue T L. Autoradiographic distribution of substance K binding sites in rat gastrointestinal tract: a comparison with substance P. Eur J Pharmacol 1984; 102: 561-562.
363. Burcher E, Buck S H, Lovenberg W, O'Donahue T L. Characterization and autoradiographic localization of multiple tachykinin binding sites in gastrointestinal tract and bladder. J Pharmacology Exp Ther 1986; 236: 819-831.
364. Burcher E, Bornstein J C. Localization of substance P binding sites in submucous plexus of guinea-pig ileum using whole mount autoradiography. Synapse 1988; 2: 232-239.
365. Rothstein R D, Johnson E, Ouyang A. Distribution of substance P receptors in the feline gastrointestinal tract using autoradiography. Gastroenterology 1991; 100: 1576-1581.
366. Parsons A M, Seybold V S, Chandan R, et al. Neurokinin receptors and mucosal ion transport in porcine jejunum. J Pharmacol Exp Ther 1992; 261: 1213-1221.
367. Mussap C J, Burcher E. Characterization and autoradiographic localization of tachykinin receptors in rat gastric fundus. J Pharmacol Exp Ther 1993; 266: 1043-1053.
368. Mantyh P W, Mantyh C R, Gates T, Vigna S R, Maggio J E. Receptor binding sites for substance P and substance K in the canine gastrointestinal tract and their possible role in inflammatory bowel disease. Neuroscience 1988; 25: 817-837
369. Mantyh P W, Gates T, Mantyh C R, Maggio J E. Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues. J Neurosci 1989; 9: 258-279.
370. Sternini C, Su D, Gamp P D, Bunnet, N W. Cellular sites of expression of the NK1 receptor in the rat gastrointestinal tract. J Comp Neurol 258: 531-540.
371. 1 receptor immunoreactivity to neurons and interstitial cells of the guinea-pig gastrointestinal tract. J Comp Neurol 1996; 367: 342-351.
372. 1 receptors in enteric neurons. Neuroscience 1996; 79: 1239-1254.
373. Mantyh C R, Pappas T N, Lapp J A. Substance P activation of enteric neurons in response to intraluminal Clostridium difficile toxin A in the rat ileum. Gastroenterology 1996; 111: 1272-1280.
374. Mantyh C R, Gates T S, Zimmermann R P, et al. Receptor binding sites for substance P but not substance K or neuromedin K are expressed in high concentrations by arterioles, venules and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc Natl Acad Sci USA 1988; 85 3235-3239.
375. Mantyh P W, Catton M D, Boehmer C G, et al. Receptors for sensory neuropeptides in human inflammatory diseases: implications for the effector role of sensory neurons. Peptides 1989; 10: 627-645.
376. Mantyh C R, Visgna S R, Bollinger R R, Mantyh P W, Maggio J E, Pappas T N. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis. Gastroenterology 1995; 109: 850-860.
377. 2 receptors in producing fast and slow atropine-resistant neurotransmission to the circular muscle of the guinea-pig colon. Neuroscience 1994; 63: 1137-1152.
378. Maggi C A, Giuliani S. Role of tachykinins as excitatory mediators of NANC contraction in the circular muscle of rat small intestine. J Autonom Pharmacol 1995; 15: 335-350.
379. 2 receptors mediate noncholinergic excitatory junction potential in the circular muscle of guinea-pig colon. Br J Pharmacol 1993; 110: 795-803.
380. 2 receptors mediate NANC excitation and contraction in the circular muscle of guinea-pig duodenum. Br J Pharmacol 1995; 115: 237-246.
381. 2 receptors mediate NANC excitatory neuromuscular transmission in the human ileum. Neuropeptides 1997; 31: 265-271.
382. Bartho L, Maggi C A, Wilhelm M, Patacchini R. Tachykinin NK1 and NK2 receptors mediate atropine-resistant excitation of the circular muscle of the guinea-pig ileum in response to capsaicin. Eur J Pharmacol 1994; 259: 187-193.
383. Holzer P, Schluet W, Maggi C A. Ascending enteric reflex contraction: roles of acetylcholine and tachykinins in relation to distension and propagation of excitation. J Pharmacol Exp Ther 1993; 264: 391-396.
384. 2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum. Br J Pharmacol 1994; 112: 161-168.
385. Foxx-Orenstein A E, Grider J R. Regulation of colonic propulsion by enteric excitatory and inhibitory transmitters. Am J Physiology 1996; 271: G433-G437
386. Giuliani S, Lecci A, Giachetti A, Maggi C A. Tachykinins and reflexly-evoked atropine-resistant motility in the guinea-pig colon in vivo. J Pharmacol Exp Ther 1993; 265: 1224-1231.
387. Giuliani S, Tramontana M, Lecci A, Maggi C A. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 1996; 354: 327-335.
388. 2 receptors in viscerosensitive response to rectal distension in rats. Gastroenterology 1994; 107: 94-102.
389. 1 receptor antagonist, decreased restraint stress-induced defecation in rat. Neurosci Letters 1995; 198: 103-106.
390. Castagliuolo I, Lamont J T, Qiu B, et al. Acute stress causes mucin release from rat colon: role of CRF and mast cells. Am J Physiology 1996; 271: G884-G892.
391. Julia V, Bueno L. Tachykininergic mediation of viscerosensitive responses to acute inflammation in rats: role of CGRP. Am J Physiology 1997; 272: G141-G146.
392. Zhao F Y, Saito K, Yoshioka K, et al. Subtypes of tachykinin receptors on tonic and phasic neurones in coeliac ganglion of the guinea-pig. Br J Pharmacol 1995; 115: 25-30.
393. Zhao F Y, Saito K, Yoshioka K, et al. Tachykininergic synaptic transmission in the coeliac ganglion of the guinea-pig. Br J Pharmacol 1996; 118: 2059-2066.
394. Jin Y, Sekizawa K, Fukushima T, Morikawa M, Nakazawa H, Sasaki H. Capsaicin desensitization inhibits swallowing reflex in guinea-pigs. Am J Resp Crit Care Med 1994; 149: 261-263.
395. 1 receptor mechanism in the ferret. Gastroenterology 1994; 106: A467.
396. Maggi C A, Patacchini R, Giachetti A, Meli A. Tachykinin receptors in the circular muscle of the guinea-pig ileum. Br J Pharmacol 1990; 101: 996-1000
397. 1 receptors of the electrically-evoked release of acetylcholine from guinea-pig myenteric neurons. Naunyn-Schmiedeberg's Arch Pharmacol 1994; 249: R88.
398. 3 receptors on cholinergic neurons in the guinea-pig ileum. NeuroSci Letters 1996; 207: 125-128.
399. Holzer P, Schluet W, Maggi C A. Substance P stimulates and inhibits intestinal peristalsis via distinct receptors. J Pharmacol Exp Therapeutics 1995; 274: 322-328.
400. Khan I, Lapierre N, Rangachari P K. Messenger RNAs for neurokinin and histamine receptor subtypes in isolated canine colonic crypts. J Pharmacol Exp Ther 1995; 272: 1285-1292.
401. Crowther R, Jukic D, Regoli D, Rangachari P K. Functional subtyping of neurokinin receptors on canine proximal mucosa. J Pharmacol Exp Ther 1994; 268: 1374-1380.
402. Brown D R, Parsons A M, O'Grady S M. Substance P produces sodium and bicarbonate secretion in porcine jejunal mucosa through an action on enteric neurons. J Pharmacol Exp Ther 1992; 261: 1206-1212.
403. 1 receptors mediate substance P-induced changes in ion transport in guinea-pig ileum. Regul Peptides 1992; 39: 215-225.
404. Cox H M, Tough I R, Grayson K, Yarrow S. Pharmacological characterisation of neurokinin receptors mediating anion secretion in rat descending colonic mucosa. Naunyn-Schmiedeberg's Arch Pharmacol 1993; 348: 172-177
405. Cooke H J, Sidhu M, Fox P, Wang Y Z, Zimmermann E M. Substance P as a mediator of colonic secretory reflexes. Am J Physiology 1997; 272: G238-G245.
406. Brunsson I, Fahrenkrug J, Jodal M, Sjoqvist A, Lundgren O. Substance P effects on blood flow fluid transport and VIP release in the feline small intestine. J Physiology 1995; 483: 727-734.
407. Wang L, Stanisz A M, Wershil B K, Galli S J, Perdue M H. Substance P induces ion secretion in mouse small intestine through effects on enteric nerves and mast cells. Am J Physiology 1995; 269: G85-G92.
408. Li Y, Owyang C. Peptone stimulates CCK-releasing peptide secretion by activating intestinal submucosal cholinergic neurons. J Clin Invest 1996; 97: 1463-1470.
409. 2 receptors in rat colonic hypersecretion induced by interleukin 1b: role of nitric oxide. Gastroenterology 1995; 109: 483-489.
410. Kraneveld A D, Buckley T L, Van Heuven-Nolsen D, Van Schaik Y, Koster A Sj, Nijkamp F P. Delayed type hypersensitivity-induced increase in vascular permeability in the mouse small intestine: inhibition by depletion of sensory neuropeptides and NK1 receptor blockade. Br J Pharmacol 1993; 114: 1483-1489.
411. Eutamene H, Theodorou V, Fioramonti J, Bueno L. Rectal distension induced colonic net water secretion in rats involves tachykinins, capsaicin sensory and vagus nerves. Gastroenterology 1997; 112: 1595-1602.
412. Pothoulakis C, Castagliuolo I, LaMont J T, et al. CP96345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not to cholera toxin. Proc Natl Acad Sci USA 1994; 91: 947-951.
413. Croci T, Landi M, Emonds X, Le Fur G, Maffrand J P, Manara L. Role of tachykinins in castor oil induced diarrhea in rats. Br J Pharmacol 1997; 121: 375-380.
414. Castagliuolo I, Keates S, Qiu B, et al. Increased substance P responses in dorsal root ganglia and intestinal macrophages during Clostridium difficile toxin A enteritis in rats. Proc Natl Acad Sci USA 1997; 94: 4788-4793.
415. Figini M, Emanueli C, Grady E F, et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiology 1997; 35: G785-G793.
416. Sann H, Dux M, Schemann M, Jancso G. Neurogenic inflammation in the gastrointestinal tract of the rat. Neurosci Letters 1996; 219: 147-150.
417. 1 receptors mediate the tachykinin stimulation of salivary secretion: selective agonists provide further evidence. Eur J Pharmacol 1988; 150: 377-379.
418. Tobin G, Ekstrom J, Bloom S R, Edwards A V. Atropine-resistant submandibular responses to stimulation of the parasympathetic innervation in the anesthetzied ferret. J Physiology 1991; 327-339.
419. Asztely A, Ekman R, Tobin G, Ekstrom J. Depletion of VIP and substance P in parotid glands of atropinized rats during reflex secretion. Exp Physiology 1996; 81: 297-303.
420. Konturek S J, Jaworek J, Tasler J, Cieszowski M, Pawlik W. Effect of substance P and its C-terminal hexapeptide on gastric and pancreatic secretion in the dog. Am J Physiology 1981; 241: G74-G81.
421. Iwatsuki K, Yamagishi F, Chiba S. Effects of substance P on pancreatic exocrine secretion stimulated by secretin dopamine and cholecystokinin in dogs. Clin Exp Pharmacol Physiol 1986; 13: 663-670.
422. 1 receptors which mediate pepsinogen secretion and are regulated by agents that increase cAMP and phospholipase C. Biochim Biophys Acta 1996; 1312: 105-116.
423. Maggi C A. The dual, sensory and 'efferent' function of the capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In: C A. Maggi, ed Nervous Control of the Urogenital System. Harwood Publisher, 1993: 383-422.
424. Maggi C A, Giuliani S, Del Bianco E, Geppetti P, Theodorsson E, Santicioli P. CGRP in the regulation of urinary tract motility. Ann New York Acad Sci 1992; 657: 328-343.
425. Cervero F, Sann H. Mechanically evoked responses of afferent fibres innervating the guinea-pig's ureter: an in vitro study. J Physiol (London) 1989; 412: 245-257.
426. Alm P, Alumets J, Brodin E, Hakanson R, Nilsson G, Sjoberg N O, Sundler F. Peptidergic (Substance P) nerves in the genitourinary tract. Neuroscience 1978; 3: 419-425.
427. Wharton J, Polak J M, Probert L, et al. Peptide containing nerves in the ureter of the guinea-pig and cat. Neuroscience 1981; 6: 969-982.
428. Sann H, Rossler W, Hammer K, Pierau Fr K. Substance P and CGRP in the ureter of chicken and guinea-pig: distribution, binding sites and possible functions. Neuroscience 1992; 49: 699-713.
429. Hua X Y, Theodorsson-Norheim E, Lundberg J M, Kinn A C, Hokfelt T, Cuello A C. Co-localization of tachykinins and CGRP in capsaicin-sensitive afferents in relation to motility effects in the human ureter in vitro. Neuroscience 1987; 23: 693-703.
430. Edyvane K A, Trussel D C, Jonavicius J, Henwood A, Marshall V R. Presence and regional variation in peptide-containing nerves in the human ureter. J Autonom Nervous System 1992; 39: 127-138.
431. Saria A, Lundberg J M, Hua X Y, Lembeck F. Sensory control of vascular permeability and capsaicin-induced substance P release and in the guinea-pig ureter. Neurosci Letters, 1983; 41: 167-170.
432. Maggi C A, Patacchini R, Eglezos A, Quartara L, Giuliani S, Giachetti A. Tachykinin receptors in the guinea-pig renal pelvis: activation by exogenous and endogenous tachykinins. Br J Pharmacol 1992; 107: 27-33.
433. Kopp U C, Smith L A. Inhibitory reno-renal reflexes: a role for substance P or other capsaicin-sensitive neurons. Am J Physiology 1991; 260: R232-R239.
434. Kopp U C, Smith L A. Effects of the substance P receptor antagonist CP-96, 345 on renal sensory receptor activation. Am J Physiol, 1993; 264: R647-R653.
435. Kopp U C, Smith L A. Role of prostaglandins in renal sensory receptor activation by SP and bradykinin. Am J Physiology 1993; 265: R544-R551.
436. Kopp U C, Farley D M, Smith L A. Renal sensory receptor activation causes prostaglandin-dependent release of SP. Am J Physiology 1996; 270: R720-R727.
437. Abelli L, Somma V, Maggi C A, et al. Effects of tachykinins and selective tachykinin receptor agonists on vascular permeability in the rat lower urinary tract: evidence for the involvement of NK1 receptors. J Autonom Pharmacol 1989; 9 253-263.
438. Nagahisa A, Kanai Y, Suga O, Taniguchi K, Tsuchiya M, Lowe III J A, Hess H J Antinflammatory and analgesic activity of a nonpeptide SP receptor antagonist. Eur J Pharmacol 1992; 217: 191-195.
439. Sharkey K A, Williams R G, Schultzberg M, Dockray G J. Sensory SP innervation of the urinary bladder: possible site of action of capsaicin in causing urine retention. Neuroscience 1983; 10: 861-868.
440. Yokokawa K, Sakanaka M, Shiosaka S, Tohyama M, Shiotani Y, Sonoda T. Three dimensional distribution of SP-like immunoreactivity in the urinary bladder of the rat. J Neural Transmission 1985; 63: 209-222.
441. Maggi C A, Santicioli P, Geppetti P, et al. Biochemical, anatomical and functional correlates of postnatal development of the capsaicin-sensitive innervation of the rat urinary bladder. Develop Brain Res 1988; 43: 183-190.
442. Wakabayashi Y, Tomoyoshi T, Fujimiya M, Arai R, Maeda T. Substance P-containing axon terminals in the mucosa of the human urinary bladder: pre-embedding immunohistochemistry using cryostat sections for electron microscopy. Histochemistry 1993; 100: 401-407
443. Burcher E, Buck S H. Multiple tachykinin binding sites in hamster rat and guinea-pig urinary bladder. Eur J Pharmacol 1986; 128: 165-177.
444. Nimmo A J, Morrison J F B, Whitaker E M. A comparison of the distribution of substance P and CGRP receptors in the rat bladder, Q J Exp Physiol 1988; 73: 789-792.
445. 1 binding sites in the rat. Peptides 1992; 13: 409-411.
446. Banasiak D, Burcher E. Effect of capsaicin on distribution of binding sites for tachykinins and CGRP in rat urinary bladder: a quantitative autoradiographic study. Peptides 1994; 15: 333-339.
447. Santicioli P, Maggi C A, Meli A. Functional evidence for the existence of a capsaicin-sensitive innervation in the rat urinary bladder. J Pharm Pharmacol 1986; 38: 446-451.
448. Maggi C A, Santicioli P, Patacchini R, et al. Regional differences in the motor response to capsaicin in the guinea-pig urinary bladder: relative role of pre- and postjunctional factors related to neuropeptide-containing sensory nerves. Neuroscience 1988; 27: 675-688.
449. Maggi C A, Patacchini R, Santicioli P, Giuliani S. Tachykinin antagonists and capsaicin-induced contraction of the rat isolated urinary bladder: evidence for tachykinin-mediated cotransmission. Br J Pharmacol 1991; 103: 1535-1541.
450. Meini S, Maggi C A. Evidence for a capsaicin-sensitive, tachykinin-mediated, component in the NANC contraction of the rat urinary bladder to nerve stimulation. Br J Pharmacol 1994; 112: 1123-1131.
451. 1 receptor in the guinea-pig isolated proximal urethra: characterization by receptor selective agonists and antagonists. Br J Pharmacol 1996; 106: 888-892.
452. Lecci A, Giuliani S, Patacchini R, Maggi C A. Evidence against a peripheral role of tachykinins in the initiation of micturition reflex in rats. J Pharmacol Exp Ther 1993; 264: 1327-1332.
453. Ishizuka O, Mattiasson A, Andersson K E. Tachykinin effects on bladder activity in conscious normal rats. J Urology 1995; 154: 257-261.
454. 2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? J Urology 1995; 154: 2034-2038.
455. Maggi C A, Parlani M, Astolfi M, et al. Neurokinin receptors in the rat lower urinary tract. J Pharmacol Exp Ther 1988; 246: 308-315.
456. Maggi C A, Abelli L, Giuliani S, et al. The contribution of sensory nerves to xylene-induced cystitis in rats. Neuroscience 1988; 26: 709-723.
457. Maggi C A, Lecci A, Santicioli P, Del Bianco E, Giuliani S. Cyclophosphamide cystitis in rats: involvement of capsaicin-sensitive primary afferents. J Autonom Nerv System 1992; 38: 201-208.
458. Ahluwalia A, Maggi C A, Santicioli P, Lecci A, Giuliani S. Characterisation of the capsaicin-sensitive component of cyclophosphamide-induced inflammation in the rat urinary bladder. Br J Pharmacol 1994; 111: 1017-1022.
459. Giuliani S, Santicioli P, Lippe ITh, Lecci A, Maggi C A. Effect of bradykinin and tachykinin receptor antagonist on xylene-induced cystitis in rats. J Urology 1993; 150: 1014-1017.
460. Abelli L, Conte B, Somma V, Parlani M, Geppetti P, Maggi C A. Mechanical irritation induces neurogenic inflammation in the rat urethra. J Urology 1991; 146: 1624-1626.
461. Maggi C A, Abelli L, Giuliani S, et al. Motor and inflammatory effect of hyperosmolar solutions on the rat urinary bladder in relation to capsaicin-sensitive sensory nerves. Gen Pharmacol 1990; 21: 97-103.
462. Maggi C A. Tachykinin antagonists in asthma and inflammation. In: S I Said, ed. Pro-Inflammatory and AntiInflammatory Peptides. New York: Marcel Dekker inc, 1997; in press
463. Baluk P, Bertrand C, Geppetti P, McDonald D, Nadel J A. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am. J Physiology 1995; 268: L263-L269.
464. 1 receptor antagonists and the role of endogenous mediators. Br J Pharmacol 1995; 114: 1343-1350
465. 1 receptors. J Immunology 1993; 80: 73-77.
466. Matsuda H, Kawakita K, Kiso Y, Nakano T, Kitamura Y. Substance P induces granulocyte infiltration through degranulation of mast cells. J Immunology 1989; 142: 927-931.
467. Yano H, Wershil B K, Arizono N, Galli S J. Substance P-induced augmentation of cutaneous vascular permeability and granulocyte infiltration in mice is mast cell dependent. J Clin Invest 1989; 84: 1276-1286.
468. Popper P, Mantyh C R, Vigna S R, Maggio J E, Mantyh P W The localization of sensory nerve fibers and receptor binding sites for sensory neuropeptides in canine mesenteric lymph nodes. Peptides 1988; 9: 257-267.
469. Payan D G. Brewster D R, Goetzl E J. Stereospecific receptors for Substance P on cultured human IM9 lymphoblasts. J Immunology 1984; 133: 3260-3265.
470. Payan D G, McGillis J P, Organist M L. Binding characteristics and affinity labeling of protein constituents of the human IM-9 lymphoblast receptor for SP. J Biol Chemistry 1986; 261: 14321-14329.
471. Payan D G, Brewster D R, Missirian-Bastian A, Goetzl E J. Substance P recognition of a subset of human T lymphocytes. J Clin Investigation 1984; 74: 1532-1539.
472. Stanisz A, Scicchitano P, Dazin J, Bienenstock J, Payan D G. Distribution of substance P receptors on murine spleen and Peyer's patch T and B cells. J Immunology 1987; 139: 749-754.
473. Roberts A I, Taunk J, Ebert E C. Human lymphocytes lack substance P receptors. Cell Immunology 1992; 141: 457-465.
474. Kavelaars A, Jeurissen F, Heijnen C J. Substance P receptors and signal transduction in leucocytes. Immunomethods 1994; 5: 41-48.
475. Weinstock J V, Blum A, Walden J, Walden T. Eosinophils from granulomas in murine schistosomiasis mansoni produce SP. J Immunology 1988; 141: 961-966.
476. 1) receptor. J Immunology 1994; 152: 1830-1835.
477. Blum A, Metwali A, Elliott D, Sandor M, Lynch R, Weinstock J V. Substance P receptor antagonist inhibits murine IgM expression in developing schistosome granulomas by blocking the terminal differentiation of intragranuloma B cells. J Neuroimmunology 1996; 66: 1-10.
478. Lotz M, Vaughan J H, Carson D A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 1988; 241 1218-1221.
479. Laurenzi M A, Persson M A A, Dalsgaard C J, Haegerstrand A. The neuropeptide substance P stimulates production of interleukin-1 in human blood monocytes: activated cells are preferentially influenced by the neuropeptide, Scand J Immunology 1990; 31: 529-534
480. Jeurissen F, Kavelaars A, Korstjens M, et al. Monocytes express a non-neurokinin substance P receptor that is functionally coupled with MAP kinase. J Immunology 1994; 152: 2987-2994.
481. Kavelaars A, Broeke D, Jeurissen F, et al. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phospholipase D, MAP kinase and IL-6 production. J Immunology 1994; 153: 3691-3699.
482. Hartung H P, Wolters K, Toyker K V. Substance P: binding properties and studies on cellular responses in guinea-pig macrophages. J Immunology 1986; 136: 3856-3863.
483. Kimball S E, Persico F J, Vaught J L. Substance P, neurokinin A and neurokinin B induce generation of interleukin-1-like activity by P388D1 cells. J Immunology 1988; 141: 3564-3569.
484. Brunelleschi S, Vanni L, Ledda F, Giotti A, Maggi C A, Fantozzi R. Tachykinins activate guinea-pig alveolar macrophages: involvement of NK2 and NK1 receptors. Br J Pharmacol 1990; 100: 417-420.
485. Pascual D W, Bost K L. A monoclonal anti-substance P antibody recognizes macrophage generated immunoreactive substance P and modulates IL-1 secretion by the same cells. FASEB J 1990; 4: A305.
486. Pascual D W, Bost K L. Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. Immunology 1990; 71: 52-56.
487. Bost K L, Breeding SAL, Pascual D W. Modulation of the mRNAs encoding SP and its receptor in rat macrophages by LPS. Immunology 1992; 4: 105-112.
488. Kincy-Cain T, Bost K L. Increased susceptibility of mice to Salmonella infection following in vivo treatment with the substance P antagonist, Spantide II. J Immunology 1996; 157: 255-264.
489. 1 receptor antagonist CP 122721: a new approach for acute and delayed emesis following cisplatin. Proc Am Soc Clin Oncol. 1996; 15: A1780.
490. 1 antagonist, CP 99994, in comparison to ibuprofen and placebo in the oral surgery model. Clin Pharmacol Ther 1996; 59: 216.
491. 1) receptor antagonist in painful peripheral neuropathy. Neurology 1994; 44: A220.
492. Goldstein D. Clinical trials with lanepitant. In: William Harvey Research Conferences, Tachykinins and their antagonists. London: October 1996: Abstract Book
493. Lundberg J M, Hokfelt T, Martling C R, Saria A, Cuello C. Substance P immunoreactive sensory nerves in the lower respiratory tract of various mammals including man. Cell Tissue Res 1984; 235: 251-261.
494. Martling C R, Saria A, Fischer J A, Hokfelt T, Lundberg J M. CGRP and the lung: neuronal coexistence with SP release by capsaicin and vasodilatory effects. Regul Peptides 1988; 20: 125-139.
495. Komatsu T, Yamamoto, Shimokata K, Nagura H. Distribution of substance P-immunoreactive and CGRP-immunoreactive nerves in normal human lungs. Int Arch Allergy Appl Immunol 1991; 95: 23-28.
496. Springall D R, Polak J M, Howard L, et al. Persistence of intrinsic neurones and possible phenotypic changes after extrinsic denervation of human respiratory tract by heart lung transplantation. Am Rev Resp Dis 1990; 141: 1538-1546.
497. Ollerenshaw S L, Jarvis D, Sullivan C E, Woolcock A J. Substance P immunoreactive nerves in airways from asthmatics and nonasthmatics. Eur Resp J 1991; 4: 673-682.
498. Howarth P H, Djukanovic R, Wilson J W, Holgate S T, Springall D R, Polak J M. Mucosal nerves in endobronchial biopsies in asthma and non-asthma. Int Arch Allergy Clin Immunol 1991; 94: 330-333.
499. Martling C R, Theodorsson-Norheim E, Lundberg J M. Occurrence and effects of multiple tachykinins, S P, NKA and neuropeptide K in human airways. Life Sciences 1987; 40: 1633-1643.
500. Nieber K, Baumgarten C, Witzel A, et al. The possible role of substance P in the allergic reaction based on two different provocation models. Int Arch Allergy Appl Immunol 1991; 94 334-338.
501. Nieber K, Baumgarten C R, Rathsack R, Furkert J, Oehme P, Kunkel G. Substance P and β-endorphin-like immunoreactivity in lavage fluids of subjects with and without allergic asthma. J Allergy Clin Immunology 1992; 90: 646-652.
502. Espiritu R F, Pittet J F, Matthay M A, Goetzl E J. Neuropeptides in pulmonary edema of adult respiratory distress syndrome. Inflammation 1992; 16: 509-517.
503. Tomaki M, Ichinose M, Miura M, et al. Elevated substance P content in induced sputum from patients with asthma and patients with chronic bronchitis. Am J Resp Crit Care Med 1995; 151: 613-617.
504. Fischer A, Kummer W, Couraud J Y, Adler D. Branscheid D, Heym C. Immunohistochemical localization of receptors for VIP and substance P in human trachea. Lab Invest 1992; 67: 387-393.
505. 1 binding sites between human and guinea-pig lung. Br J Pharmacol 1994; 113: 1407-1415.
506. Adcock I M, Peters M, Gelder C, Shirasaki H. Brown C R, Barnes P J. Increased tachykinin receptor gene expression in asthmatic lung and its modulation by steroids. J Mol Endocrinology 1993; 11: 1-7.
507. 2) receptor gene expression in inflammatory airway disease. Am J Physiology 1995; 269: L309-L317
508. 2 type. Eur J Pharmacol 1990; 178: 215-219.
509. 2 receptor in the human bronchus: influence of amastatin-sensitive pathway. Br J Pharmacol 1994; 111: 570-574.
510. 1 receptors on human isolated small bronchi. Am J Physiology 1996; 271: L763-L767
511. Barnes P J, Dewar A, Rogers D F. Human bronchial secretion: effect of SP, muscarinic and adrenergic stimulation in vitro. Br J Pharmacol 1986; 89: 767P.
512. Ujiie Y, Sekizawa K, Aikawa T, Sasaki H. Evidence for substance P as an endogenous substance causing cough in guinea-pigs. Am Rev Resp Dis 1993; 148: 1628-1632.
513. Takahama K, Fuchikami J, Kai H, Isohama Y, Miyata T. Inhalation of phosphoramidon, a neutral endopeptidase inhibitor, induces cough in awake guinea-pigs. Arch Int Pharmacodyn Ther 1995; 330: 241-250.
514. Sekizawa K, Ebihara T, Sasaki H. Role of substance P in cough during bronchoconstriction in awake guinea-pigs. Am J Resp Crit Care Med 1995; 151: 815-821.
515. Yasumitsu R, Hirayama Y., Imai T, Miyayasu K A, dHiroi J. Effects of specific tachykinin receptor antagonists on citric acid-induced cough and bronchoconstriction in unanaesthetized guinea-pigs. Eur J Pharmacol 1996; 300: 215-219.
516. Girard V, Naline E, Vilain P, Emonds-Alt X, Advenier C. Effect of the two tachykinin antagonists, SR 48968 and SR 140333, on cough induced by citric acid in the unanesthetized guinea-pig. Eur Resp J 1995; 8: 1110-1114.
517. 2 tachykinin receptor antagonists CP 99994 and SR 48968 in the guinea-pig and cat. Br J Pharmacol 1997; 121: 165-170.
518. Ichinose M, Nakajima N, Takahashi T, Yamauchi H, Inoue H, Takishima T. Protection against bradykinin-induced bronchoconstriction in asthmatic patients by neurokinin receptor antagonist. The Lancet 1992; 340: 1248-1251.
519. Joos G F, Kips J C, Peleman R A, Pauwels R A. Tachykinin antagonists and the airways. Arch Int Pharmacodyn 1995; 329: 205-219.
520. 2 receptor antagonist on NKA-induced bronchoconstriction in asthmatics. Am J Resp Crit Care Med 1996; 153: 1781-1784.
521. Schmidt D, Jorres R A, Rabe K F, Magnussen H. Reproducibility of airway response to inhaled bradykinin and the effect of the neurokinin receptor antagonist FK 224 in asthmatic subjects. Eur J Clin Pharmacol 1996; 50: 269-273.
522. Lunde H, Hedner J, Svedmyr N. Lack of 4 weeks treatment with the neurokinin receptor antagonist FK 224 in mild to moderate asthma. Eur Resp J 1994; Supp 18: 7: 151s.
523. 1 receptor antagonist (CP 99994) on hypertonic saline-induced bronchoconstriction and cough in male asthmatic subjects. Am J Resp Crit Care Med 1995; 152: 879-884.
524. 1 receptor antagonist improves exercise-induced airway narrowing in asthmatic patients. Am J Respir Crit Care Med 1996; 153: 936-941.
525. Lundblad L, Lundberg J M, Brodin E, Anggard A. Origin and distribution of capsaicin-sensitive substance P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol 1983; 96: 485-493.
526. Baraniuk J N, Lundgren J D, Okayama M, Merida M, Kaliner M A. Substance P and neurokinin A in human nasal mucosa. Am J Resp Cell Mol Biol 1991; 4: 228-236.
527. Lundblad L, Anggard A, Lundberg J M. Effects of antidromic trigeminal nerve stimulation in relation to parasympathetic vasodilatation in the cat nasal mucosa. Acta Physiol Scand 1983; 119: 7-13.
528. Asakura K, Shirasaki H, Narita S, Kojima T, Kataura A. Study on the dye leakage response of nasal mucosa following topical capsaicin challenge in guinea-pigs. Acta Otolaryngol 1992; 112: 545-551.
529. Petersson G, Malm L, Ekman R, Hakanson R. Capsaicin evokes secretion of nasal fluid and depletes substance P and CGRP from the nasal mucosa in the rat. Br J Pharmacol 1989; 98: 930-936.
530. Abe Y, Takeda N, Irifune M, et al. Effects of capsaicin desensitization on nasal allergy-like symptoms and histamine release in the nose induced by toluene diisocyanate in guineapigs. Acta Otolaryngol 1992; 11: 703-709.
531. 1 tachykinin receptors. J Pharmacol Exp Ther 1993; 265: 36-40.
532. 1 receptors in plasma protein extravasation induced by tachykinins in the guinea-pig upper airways. Neuropeptides 1997; 31: 65-70.
533. Tonnesen P, Schaffalitzky de Muckadell O B. Substance P and VIP in serotonin-induced nasal secretions in normal subjects. Allergy 1987; 42: 146-150.
534. Mosimann B L, White M V, Hohman R J, Goldrich M S, Kaulbach H C, Kaliner M A. Substance P, CGRP and VIP increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunology 1993; 92: 95-104.
535. Schierhorn K, Brunnee T, Schultz K D, Jahnke V, Kunkel G. Substance P-induced histamine release from human nasal mucosa in vitro. Int Arch Allergy Immunology 1995; 107: 109-114.
536. Okamoto Y, Shirotori K, Kudo K, et al. Cytokine expression after the topical administration of substance P to human nasal mucosa. J Immunology 1993; 151: 4391-4398.
537. Devillier P, Dessangies J F, Rakotosihanaka F, et al. Nasal response to substance P and methacholine in subjects with and without allergic rhinitis. Eur Resp J 1988; 1: 356-361.
538. Konno A, Numata T, Terada N, Hanazawa T, Nagata H, Motosugi H. Role of substance P in the vascular response of nasal mucosa in nasal allergy. Annals Otology Rhinol Laryngol 1996; 105: 648-653.
539. Baumgarten C R, Witzel A, Kleine-Tebbe J, Kunkel G. Substance P enhances antigen-evoked mediator release from human nasal mucosa. Peptides 1996; 17: 25-30.
540. Braunstein G, Fajac I, Lacronique J, Frossard N. Clinical and inflammatory responses to exogenous tachykinins in allergic rhinitis. Am Rev Resp Dis 1991; 144: 630-635.
541. Baraniuk J N, Ohkubo K, Kwon O J, et al. Identification of neutral endopeptidase mRNA in human nasal mucosa. J Appl Physiology 1993; 74: 272-279.
542. Baraniuk J N, Kaliner M. Neuropeptides and nasal secretion. Am J Physiol 1991; 261: L223-L235.
543. Bjorklund H, Dalsgaard C J, Jonsson C E, Hermansson A. Sensory and autonomic innervation of nonhairy and hairy human skin. Cell Tissue Res 1986; 243: 51-57.
544. Wallengren J, Ekman R, Sundler F. Occurrence and distribution of neuropeptides in the human skin. Acta Derm Venereol 1987; 67: 185-192.
545. Alvarez F J, Cervantes C, Blasco I, et al. Presence of CGRP and substance P immunoreactivity in intraepidermal free nerve endings of cat skin. Brain Res 1988; 442: 391-395.
546. Foreman J C, Jordan C C, Oehme P, Renner H. Structure-activity relationships for some substance P-related peptides that cause wheal and flare reactions in human skin. J Physiology 1983; 335: 449-465.
547. Devillier P, Regoli D, Asseraf A, Descours B, Marsac J, Renoux M. Histamine release and local responses of rat and human skin to substance P and other mammalian tachykinins. Pharmacology 1986; 32: 340-347.
548. Gamse R, Saria A. Potentiation of tachykinin-induced plasma protein extravasation by CGRP. Eur J Pharmacol 1985; 114: 61-66.
549. Couture R, Kerouac R. Plasma protein extravasation induced by mammalian tachykinins in rat skin: influence of anesthetic agents and an acetylcholine antagonist. Br J Pharmacol 1987; 91: 265-273.
550. 1 receptor mediation of neurogenic plasma extravasation in rat skin. Br J Pharmacol 1989; 97: 1232-1238.
551. Jacques L, Couture R, Drapeau G, Regoli D. Capillary permeability induced by intravenous neurokinins, receptor characterization and mechanism of action. Naunyn-Schmiedeberg's Arch Pharmacol 1989; 340: 170-179.
552. Ahluwalia A, Giuliani S, Maggi C A. Demonstration of septide-sensitive inflammatory response in rat skin. Br J Pharmacol 1995; 116: 2170-2174.
553. Wallengren J, Hakanson R. Effects of substance P, NKA and CGRP in human skin and their involvement in sensory nerve mediated responses. Eur J Pharmacol 1987; 143: 267-273.
554. Fuller R W, Conradson T B, Dixon C M S, Crossman D C, Barnes P J. Sensory neuropeptide effects in human skin. Br J Pharmacol 1987; 92: 781-788.
555. 125I]Bolton-Hunter substance P binding sites in human and rat skin. Neurosci Letters 1989; 99: 287-292.
556. Lundblad L, Lundberg J M, Anggard A, Zetterstrom O. Capsaicin-pretreatment inhibits the flare component of the cutaneous allergic reaction in man. Eur J Pharmacol 1985; 113: 461-462.
557. Lundblad L, Lundberg J M, Anggard A, Zetterstrom O. Capsaicin-sensitive nerves and the cutaneous allergy reaction in man. Allergy 1987; 42: 20-25.
558. Helme R D, McKernan S. Neurogenic flare responses following topical application of capsaicin in humans. Ann Neurology 1985; 18: 505-509.
559. Delay-Goyet P, Satoh H, Lundberg J M. Relative involvement of substance P and CGRP mechanisms in antidromic vasodilatation in the rat skin. Acta Physiol Scand 1992; 146: 537-538.
560. Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A. The non peptide tachykinin antagonist, CP-96, 345 is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 1992; 105: 527-530.
561. 1 receptor antagonist RP 67580, inhibits neurogenic inflammation postsynaptically. Br J Pharmacol 1993; 109: 259-264.
562. Inoue H, Nagata N, Koshihara Y. Involvement of substance P as a mediator of capsaicin-induced mouse ear oedema. Inflamm Res 1995; 44: 470-474.
563. Inoue H, Nagata N, Koshihara Y. Effect of the tachykinin receptor antagonists SR 140333, FK 888 and SR 142801 on capsaicin-induced mouse ear oedema. Inflammation Res 1996; 45: 303-307.
564. 1 receptor antagonist on oedema formation induced by tachykinins carrageenin and an allergic response in guinea-pig skin. Neuropeptides 1994; 26: 405-411.
565. Eschenfelder C C, Benrath J, Zimmermann M, Gillardon F. Involvement of substance P in ultraviolet irradiation-induced inflammation in rat skin. Eur J Neuroscience 1995; 7: 1520-1526.
566. 1 receptor antagonist, SR 140333 on oedema formation induced in rat skin by venom from the Phoneutria nigriventer spider. Br J Pharmacol 1996; 118: 295-298.
567. 1 antagonist on antigen-induced oedema formation in rat skin. J Lipid Mediator and Cell Signalling 1996; 13: 223-232.
568. Siney L, Brain S D. Involvement of sensory neuropeptides in the development of plasma extravasation in rat dorsal skin following thermal injury. Br J Pharmacol 1996; 117: 1065-1070.
569. 1 receptors. J Neuroimmunology 1996; 65: 119-124.
570. Maggi C A, Borsini F, Santicioli P, et al. Cutaneous lesions in capsaicin-pretreated rats - a trophic role of capsaicin-sensitive afferents? Naunyn-Schmiedeberg's Arch Pharmacol 1987; 336: 538-545.
571. Nilsson J, Von Euler A M, Dalsgaard C J. Stimulation of connective tissue cell growth by substance P and substance K. Nature 1985; 315: 61-63.
572. 1 receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 1990a; 100: 11-14.
573. 1 receptor stimulation in human skin fibroblasts. Neuropeptides 1996; 30: 345-354.
574. 1 receptor mediates the migration-promoting effect of substance P on human skin fibroblasts in culture. Naunyn-Schmiedeberg's Arch Pharmacol 1995; 353: 475-481.
575. Kahler C M, Sitte BA, Reinisch N, Wiedermann C J. Stimulation of the chemotactic migration of human fibroblasts by substance P. Eur J Pharmacol 1993; 249: 281-286.
576. Kahler C M, Herold M, Wiedermann C J. Substance P: a competence factor for human fibroblast proliferation that induces the release of growth-regulatory arachidonic acid metabolites. J Cell Physiology 1993; 156: 579-587.
577. Tanaka T, Danno K, Ikai K, Imamura S. Effects of substance P and substance K on the growth of cultured keratinocytes. J Invest Dermatol 1988; 90: 399-401.
578. Wilkinson D I. Mitogenic effect of substance P and CGRP on keratinocytes. J Cell Biology 1989; 107: 509.
579. Benrath J, Zimmermann M, Gillardon F. Substance P and nitric oxide mediate wound healing of ultraviolet photodamaged rat skin: evidence for an effect of nitric oxide on keratinocyte proliferation. Neurosci Letters 1995; 200: 17-20.
580. Hukkanen M, Konttinen Y T, Rees R G, Gibson S J, Santavirta S, Polak J M. Innervation of bone from healthy and arthritic rats by substance P and CGRP containing sensory fibers. J Rheumatol 1992; 19: 1252-1259.
581. Hukkanen M, Konttinen Y T, Rees R G, Santavirta S, Terenghi G, Polak J M. Distribution of nerve endings and sensory neuropeptides in rat synovium, meniscus and bone. Int J Tiss React 1992; 14: 1-10.
582. Mapp P I, Kidd B L, Gibson S J, et al. Substance P-, CGRP- and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis. Neuroscience 1990; 37: 143-153.
583. Buma P, Verschuren C, Versleyen D, Van der Kraan P, Oestricher A B. CGRP, substance P and gap-43/B-50 immunoreactivity in the normal and arthrotic knee joint of the mouse. Histochemistry 1992; 98: 327-339.
584. Pereira da Silva J A, Carmo-Fonseca M. Peptide containing nerves in human synovium: immunohistochemical evidence for decreased innervation in rheumatoid arthritis. J Rheumatol 1990; 17: 1592-1599.
585. Lembeck F, Donnerer J, Colpaert F C. Increase of Substance P in primary afferent nerves during chronic pain. Neuropeptides 1981; 1: 175-180.
586. Colpaert FC, Donnerer J, Lembeck F. Effects of capsaicin on inflammation and on the substance P content of nervous tissues in rats with adjuvant arthritis. life Sci 1983; 32: 1827-1834.
587. Schoenen J, Van Hees J, Gybels J, De Castro-Costa M, Vanderhaegen J J. Histochemical changes of Substance P, FRAP, serotonin and succinic dehydrogenase in the spinal cord of rats with adjuvant arthritis. Life Sci 1985; 36: 1247-1254.
588. Minami M, Kuraishi Y, Kawamura M, et al. Enhancement of preprotachykinin A gene expression by adjuvant-induced inflammation in the rat spinal cord: possible involvement of substance P-containing spinal neurons in nociception. Neurosci Letters 1989; 98: 105-110.
589. 1 receptor gene expression in models of pain and inflammation, Can J Physiol Pharmacol 1995; 73: 854-859
590. Oku R, Satoh M, Takagi H. Release of substance P from the spinal dorsal horn is enhanced in polyarthritic rats. NeuroSci Letters 1987; 74: 315-319.
591. Schaible H G, Jarrott B, Hope P J, Duggan A W. Release of immunoreactive substance P in spinal cord during development of acute arthritis in the knee joint of the cat: a study with antibody microprobes. Brain Res 1990; 529: 214-223.
592. 1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat. Br J Pharmacol 1996; 117: 196-202
593. Levine J D, Clark R, Devor M, Helms C, Moskowitz M A, Basbaum AI. Intraneuronal Substance P contributes to the severity of experimental arthritis. Science 1984; 226: 547-549.
594. Yaksh T L. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res 1988; 458: 319-324.
595. Ferrell W R, Russell N J W. Plasma extravasation in the cat knee joint induced by antidromic articular nerve stimulation. Pflugers Archiv 1985; 404: 91-93.
596. Ferrell W R, Russell N J W. Extravasation in the knee induced by antidromic stimulation of articular C fibre afferents of the anesthetized cat. J Physiol 1986; 379: 407-416.
597. Coderre T J, Basbaum A I, Levine J D. Neural control of vascular permeability: interactions between primary afferents, mast cells and sympathetic efferents. J Neurophysiology 1989; 62: 48-58.
598. Khoshbaten A, Ferrell W R. Alterations in cat knee joint blood flow induced by electrical stimulation of articular afferents and efferents. J Physiol 1990; 430: 77-86.
599. Lam F Y, Ferrell W R. Specific neurokinin receptors mediate plasma extravasation in the rat knee joint. Br J Pharmacol 1991; 103: 1263-1267
600. 1 receptors mediate tachykinin-induced plasma extravasation in the rat knee joint. Agents Actions 1993; 40: 171-175.
601. Lam F J, Wong M C S. Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat. Br J Pharmacol 1996; 118: 2107-2114.
602. Walsh D A, Mapp P I, Wharton J, et al. Localisation and characterisation of substance P binding to human synovial tissue in rheumatoid arthritis. Ann Rheum Disease 1992; 51: 313-317
603. Walsh D A, Salmon M, Mapp P I, et al. Microvascular substance P binding to normal and inflamed rat and human synovium. J Pharmacol Exp Ther 1993; 267: 951-960.
604. Lotz M, Carson D A, Vaughan JH. Substance P activation of rheumatoid synoviocytes: neural pathway pathogenesis of arthritis. Science 1992; 235: 893-895.
605. Tanabe T, Otani H, Mishima K, Ogawa R, Inagaki C. Mechanisms of oxyradical production in substance P stimulated rheumatoid synovial cells. Rheumatol Int 1996; 16: 159-167
606. Devillier P, Weill B, Renoux C. Elevated levels of tachykinin-like immunoreactivity in joint fluids from patients with rheumatic inflammatory diseases. New Engl J Medicine 1986; 314: 1323.
607. Marshall K W, Chin B, Inman RD. Substance P and arthritis: analysis of plasma and synovial fluid levels. Arthritis Rheumatism 1990; 33: 87-90.
608. Marabini S, Matucci-Cerinic M, Geppetti P, Del Bianco E, Marchesoni A, Tosi S, Cagnoni M, Partsch G. Substance P and somatostatin levels in rheumatoid arthritis, osteoarthritis and psoriatic arthritis synovial fluid. Ann New York Acad Sci 1991; 632: 435-436.
609. Sacerdote P, Carrabba M, Galante A, Pisati R, Manfredi B, Panerai AE. Plasma and synovial fluid interleukin-1, interleukin-6 and substance P concentrations in rheumatoid arthritis patients: effect of the nonsteroidal antinflammatory drugs indomethacin, diclofenac and naproxen. Inflamm Res 1995; 44: 486-490.
610. Costa M, Furness J B, Llewellyn-Smith I J. Histochemistry of the enteric nervous system. In: L R Johnson, ed. Physiology of the gastrointestinal tract, 2nd Edition. New York: Raven Press, 1987; 1-40.
611. Holzer P, Gamse R, Lembeck F. Distribution of Substance P in the rat gastrointestinal tract - lack of effect of capsaicin pretreatment. Eur J Pharmacol 1980; 61: 303-307
612. Koch T R, Carney J A, Go V L. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases. Dig Dis Sci 1987; 32: 369-376.
613. Goldin E, Karmeli F, Selinger Z, Rachmilevitz D. Colonic Substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation. Dig Dis Sci 1989; 34: 754-757.
614. Keranen U, Kiviluoto T, Jarvinen H, Back N, Kivilaakso E, Soinila S. Changes in substance P immunoreactive innervation of human colon associated with ulcerative colitis. Dig Dis Sci 1995; 40: 2250-2258.
615. Keranen U, Jarvinen H, Kiviluoto T, Kivilaakso E, Soinila S. Substance P and VIP-immunoreactive innervation in normal and inflamed pouches after restorative proctocolectomy for ulcerative colitis. Dig Dis Sci 1996a; 41: 1658-1664.
616. Keranen U, Jarvinen H, Karkkainen P, Kiviluoto T, Kivilaakso E, Soinila S. Substance P - an underlying factor for pouchitis? Prospective study of substance P and VIP-immunoreactive innervation and mast cells. Dig Dis Sci 1996b; 41: 1665-1671.
617. Eysselein V E, Reinshagen M, Cominelli F, et al. CGRP and substance P decrease in rabbit colon during colitis: a time study. Gastroenterology 1991; 101: 1211-1219.
618. Reinshagen M, Adler G, Eysselein V E. Substance P gene expression in acute experimental colitis. Regul Peptides 1995; 59: 53-58.
619. Mantyh C R, Vigna S R, Maggio J E, Mantyh P W, Bollinger R R, Pappas T N. Substance P binding sites on intestinal lymphoid aggregates and blood vessels in inflammatory bowel disease correspond to authentic NK1 receptors. Neurosci Letters 1994; 178: 255-259.
620. Mantyh C R, Maggio J E, Mantyh P W, Vigna S R, Pappas T N. Increased substance P receptor expression by blood vessels and lymphoid aggregates in Clostridium difficile-induced pseudomembraneous colitis. Dig Dis Sci 1996; 41: 614-620.
621. Abelli L, Conte B, Somma V, Parlani M, Geppetti P, Maggi C A. Mechanical irritation induces neurogenic inflammation in the rat urethra. J Urology 1991; 146: 1624-1626.
622. Christmas T J, Rode J, Chapple C R, Milroy E J, Turner Warwick R T. Nerve fibre proliferation in interstitial cystitis. Virchows Arch 1990; 416: 447-451.
623. Pang X, Marchand J, Sant G R, Kream R M, Theoharides T C. Increased number of Substance P positive nerve fibers in interstitial cystitis. Br J Urology 1995; 75: 744-750.
624. Edvinsson L, Uddman R. Adrenergic, cholinergic and peptidergic nerve fibres in dura mater - involvement in headache? Cephalalgia 1981; 1: 175-179.
625. Edvinsson L, Rosendal-Helgesen S, Uddman R. Substance P: localization, concentration and release in cerebral arteries, choroid plexus and dura mater. Cell Tissue Res 1983; 234: 1-7.
626. Suzuki N, Hardebo J E, Owman C. Origins and pathways of cerebrovascular nerves storing substance P and CGRP in rat. Neuroscience 1989; 31: 427-438.
627. Keller J T, Marfurt C F. Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol 1991; 309: 5515-534
628. Geppetti P, Del Bianco E, Santicioli P, Lippe I Th, Maggi C A, Sicuteri F. Release of sensory neuropeptides from durai venous sinuses of guinea-pig. Brain Res 1990; 510: 58-62.
629. Zagami A S, Goadsby P J, Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides 1990; 16: 69-75.
630. Markowitz S, Saito K, Moskowitz M A. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987; 7: 4129-4136.
631. 1 receptor antagonist, RP 67, 580, blocks neurogenic plasma extravasation in the dura mater of rats. Br J Pharmacol 1993; 108: 11-12.
632. 1 receptor antagonist) of neurogenic plasma protein extravasation within guinea-pig dura mater and conjunctiva. Br J Pharmacol 1994; 112: 920-924.
633. 1 antagonist CP 99994 on plasma extravasation in dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats. Neuropharmacology 1995; 34: 255-261.
634. 1 receptor antagonist, in the trigeminovascular system. Regul Peptides 1997; 68: 23-29.
635. Dimitriadou V, Buzzi M G, Moskowitz M A, Theoharides T C. Trigeminal sensory fibers stimulation induces morphological changes reflecting secretion in rat dura mater mast cells. Neuroscience 1991; 44: 97-112.
636. Dimitriadou V, Buzzi M G, Theoharides T C, Moskowitz M A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 1992; 48: 187-203.
637. Saito K, Markowitz S, Moskowitz M A. Ergot alkaloids block neurogenic extravasation in dura mater: proposed action in vascular headaches. Ann Neurol 1988; 24: 732-737.
638. Buzzi M G, Moskowitz M A. The antimigraine drug sumatriptan (GR 43175) selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99: 202-206
639. Buzzi M G, Carter W B, Shimizu T, Heath III H, Moskowitz M A. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991; 30: 1193-1200.
640. 1 receptor antagonists: prospects for the treatment of migraine headache. Can J Physiol Pharmacol 1995; 73: 871-877
641. Carmody J, Pawlak M, Messlinger K. Lack of a role for substance P in the control of durai arterial flow. Exp Brain Res 1996; 111: 424-428.
642. Moskowitz M A, Buzzi M G. Neuroeffector functions of sensory fibres: implications for headache mechanisms and drug actions. J Neurology 1991; 238: S18-S22.
643. Elliott J, Seward E M. Neurokinin receptor antagonists. Exp Opin Ther Patents 1997; 7: 43-54.
644. 1 antagonist in acute migraine: a crossover study. Clin Pharm Ther 1997; 61: 142.